CK1G1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| O00566 | S171 | Sugiyama | MPHOSPH10 MPP10 | RAENSSKsDLRKsPVFsDEDsDLDFDISKLEQQSKVQNKGQ |
| O00571 | S70 | Sugiyama | DDX3X DBX DDX3 | KGFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGs |
| O14980 | S450 | Sugiyama | XPO1 CRM1 | VLVVENDQGEVVREFMKDTDsINLyKNMRETLVyLTHLDyV |
| O15523 | S70 | Sugiyama | DDX3Y DBY | KGFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSG |
| O43390 | S23 | Sugiyama | HNRNPR HNRPR | NQVNGNAVQLKEEEEPMDtssVTHTEHYKtLIEAGLPQKVA |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S300 | Sugiyama | CALU | NKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF_____ |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T303 | Sugiyama | CALU | GKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF________ |
| O60231 | S112 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRKKR |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60701 | S392 | Sugiyama | UGDH | PREQIVVDLsHPGVSEDDQVsRLVTISKDPYEACDGAHAVV |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O75581 | T1479 | SIGNOR|PSP | LRP6 | PYDRAHVTGASSSSSssTKGtYFPAILNPPPsPAtERsHYT |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95302 | S275 | Sugiyama | FKBP9 FKBP60 FKBP63 | NPKDSISIENKVVPENCERIsQsGDFLRYHYNGTLLDGTLF |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05556 | S509 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | CRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSEICSNNG |
| P05787 | S258 | Sugiyama | KRT8 CYK8 | QISDTSVVLsMDNSRsLDMDsIIAEVKAQyEDIANRsRAEA |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07948 | S13 | SIGNOR|PSP | LYN JTK8 | ________MGCIKSKGKDsLsDDGVDLKTQPVRNTERTIyV |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08670 | S214 | Sugiyama | VIM | LQREEAENtLQsFRQDVDNAsLARLDLERKVEsLQEEIAFL |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09960 | S240 | Sugiyama | LTA4H LTA4 | LVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYVWGQYDLL |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG47 | T55 | Sugiyama | UBB | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | T55 | Sugiyama | UBC | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | S158 | Sugiyama | EIF2S2 EIF2B | EILEKDEALEDEDNKKDDGIsFsNQtGPAWAGSERDytyEE |
| P20810 | S311 | Sugiyama | CAST | LEALsAsLGTRQAEPELDLRsIKEVDEAKAKEEKLEKCGED |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P25054 | S1504 | PSP | APC DP2.5 | DADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRI |
| P25054 | S1505 | PSP | APC DP2.5 | ADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRIM |
| P25054 | S1507 | PSP | APC DP2.5 | TLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRIMPP |
| P25054 | S1510 | PSP | APC DP2.5 | HFATESTPDGFsCsssLsALsLDEPFIQKDVELRIMPPVQE |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26641 | S304 | Sugiyama | EEF1G EF1G PRO1608 | PKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLWyS |
| P26641 | T302 | Sugiyama | EEF1G EF1G PRO1608 | HLPKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLW |
| P27797 | S195 | Sugiyama | CALR CRTC | IVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDAsK |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28340 | S60 | Sugiyama | POLD1 POLD | LMEEMEAEHRLQEQEEEELQsVLEGVADGQVPPsAIDPRWL |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30043 | S198 | Sugiyama | BLVRB FLR SCAN | KHDLGHFMLRCLttDEyDGHstyPsHQyQ____________ |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P31327 | S1090 | Sugiyama | CPS1 | KNGVKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVN |
| P31327 | S1093 | Sugiyama | CPS1 | VKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVNTLN |
| P31327 | S863 | Sugiyama | CPS1 | LSEPSsTRIyAIAKAIDDNMsLDEIEKLTYIDKWFLYKMRD |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35580 | S1013 | Sugiyama | MYH10 | QNSKFIKEKKLMEDRIAECssQLAEEEEKAKNLAKIRNKQE |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40925 | S326 | Sugiyama | MDH1 MDHA | NDFSREKMDLTAKELtEEKEsAFEFLssA____________ |
| P40925 | T321 | Sugiyama | MDH1 MDHA | EGLPINDFSREKMDLTAKELtEEKEsAFEFLssA_______ |
| P42696 | T91 | Sugiyama | RBM34 KIAA0117 | YVPVPKQTIKKTKRNEEEEstsQIERPLsQEPAKKVKAKKK |
| P43487 | S188 | Sugiyama | RANBP1 | KAGSGKNDHAEKVAEKLEALsVKEETKEDAEEKQ_______ |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49368 | T484 | Sugiyama | CCT3 CCTG TRIC5 | tSLRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQ |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55884 | S185 | Sugiyama | EIF3B EIF3S9 | EEELLGDVLKDRPQEADGIDsVIVVDNVPQVGPDRLEKLKN |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62495 | S295 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | LSNVKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62979 | T55 | Sugiyama | RPS27A UBA80 UBCEP1 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P62987 | T55 | Sugiyama | UBA52 UBCEP2 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q00610 | S1494 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEFRRIAAYL |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02952 | S1256 | Sugiyama | AKAP12 AKAP250 | QSKMEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTK |
| Q02952 | S1259 | Sugiyama | AKAP12 AKAP250 | MEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTKDVP |
| Q04206 | S536 | PSP | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q07021 | S201 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | ALVLDCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKD |
| Q07021 | S205 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYT |
| Q07021 | S87 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | CGCGCGSLHTDGDKAFVDFLsDEIKEERKIQKHKTLPKMsG |
| Q07157 | S1065 | Sugiyama | TJP1 ZO1 | YVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVP |
| Q12778 | S322 | SIGNOR|iPTMNet | FOXO1 FKHR FOXO1A | HsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGD |
| Q12778 | S325 | SIGNOR | FOXO1 FKHR FOXO1A | DDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGDVHS |
| Q12906 | S190 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | HLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALASL |
| Q12965 | S1009 | Sugiyama | MYO1E MYO1C | yTsMARPPLPRQQstssDRVsQtPEsLDFLKVPDQGAAGVR |
| Q13435 | S317 | Sugiyama | SF3B2 SAP145 | ETDARssLGQsAsEtEEDtVsVsKKEKNRKRRNRKKKKKPQ |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q14151 | S195 | Sugiyama | SAFB2 KIAA0138 | AQPPEHAVDGEGFKNtLEtssLNFKVtPDIEEsLLEPENEK |
| Q14151 | S246 | Sugiyama | SAFB2 KIAA0138 | sEPVKEEssELEQPFAQDtssVGPDRKLAEEEDLFDsAHPE |
| Q14192 | S257 | Sugiyama | FHL2 DRAL SLIM3 | IsFEERQWHNDCFNCKKCsLsLVGRGFLTERDDILCPDCGK |
| Q14257 | S146 | Sugiyama | RCN2 ERC55 | MyDRVIDFDENtALDDAEEEsFRKLHLKDKKRFEKANQDSG |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14498 | T330 | Sugiyama | RBM39 HCC1 RNPC2 | QLNGFELAGRPMKVGHVTERtDAssAssFLDsDELERtGID |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14C86 | S740 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | LPSDSEAPDLKQEERLQELEsCsGLGstSDDTDVREVSSRP |
| Q15056 | S94 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | RDKDTDKFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVD |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15181 | S127 | Sugiyama | PPA1 IOPPP PP | NDKHTGCCGDNDPIDVCEIGsKVCARGEIIGVKVLGILAMI |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15424 | S247 | Sugiyama | SAFB HAP HET SAFB1 | sEPVKEEssELEQPFAQDtssVGPDRKLAEEEDLFDsAHPE |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S305 | Sugiyama | HSP90AB2P HSP90BB | RVVYMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKR |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5UIP0 | S1693 | Sugiyama | RIF1 | NLRTRNAIKRLHKRDsFDNCsLGESSKIGIsDIssLsEKtF |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q6NZY4 | S605 | Sugiyama | ZCCHC8 | EIFTKKsEAGHAssPDsEVTsLCQKEKAELAPVNTEGALLD |
| Q6P996 | S718 | Sugiyama | PDXDC1 KIAA0251 | KQRLPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssG |
| Q6P996 | S721 | Sugiyama | PDXDC1 KIAA0251 | LPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQ |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PCE3 | S311 | Sugiyama | PGM2L1 BM32A | QKDPDPDFSTVKCPNPEEGEsVLELsLRLAEKENARVVLAT |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ULP2 | S582 | Sugiyama | AFTPH AFTH | SSAGPSQVVDWNAFEDEQKDsCsWAAFGDQQATESHHRKEA |
| Q6ULP2 | S584 | Sugiyama | AFTPH AFTH | AGPSQVVDWNAFEDEQKDsCsWAAFGDQQATESHHRKEAWQ |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q8IWS0 | S183 | Sugiyama | PHF6 CENP-31 KIAA1823 | RKGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRsPHRs |
| Q8IWS0 | S184 | Sugiyama | PHF6 CENP-31 KIAA1823 | KGRPRKTNFKGLSEDtRstssHGtDEMEsssyRDRsPHRss |
| Q8N5F7 | S266 | Sugiyama | NKAP | SKKYKKKRSKKSRKESSDSSsKEsQEEFLENPWKDRTKAEE |
| Q8N5F7 | S269 | Sugiyama | NKAP | YKKKRSKKSRKESSDSSsKEsQEEFLENPWKDRTKAEEPSD |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8N6T3 | T350 | Sugiyama | ARFGAP1 ARF1GAP | ETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSA |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q99622 | S97 | Sugiyama | C12orf57 C10 | GVLKFARLVKSYEAQDPEIAsLSGKLKALFLPPMTLPPHGP |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BTC0 | S352 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | TADQQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEK |
| Q9BTC0 | T355 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | QQEAKWRPGDADGTDCTsIGtIEQKSSEDQGIKGRIEKAAN |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BWU0 | S709 | Sugiyama | SLC4A1AP HLC3 | SRGELKKKKTPGPGKLPPTLsSKYPEDDPDYCVWVPPEGQS |
| Q9BY32 | S53 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | CTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQGPVLVEDT |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9GZZ9 | T386 | Sugiyama | UBA5 UBE1DC1 | EGITVAytIPKKQEDsVTELtVEDSGESLEDLMAKMKNM__ |
| Q9H3P7 | S393 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | SMWTRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEG |
| Q9H3P7 | T396 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | TRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEGSYL |
| Q9NQE9 | S46 | Sugiyama | HINT3 | VssVGTCEAAGKsPEPKDyDstCVFCRIAGRQDPGTELLHC |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR30 | S466 | Sugiyama | DDX21 | ETKKEAQELSQNsAIKQDAQsLHGDIPQKQREITLKGFRNG |
| Q9NX58 | S32 | Sugiyama | LYAR PNAS-5 | sVKKIQVEKHVSVCRNCECLsCIDCGKDFWGDDYKNHVKCI |
| Q9NZL9 | S110 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | IVHCAAERRPDVVENQPDAAsQLNVDASGNLAKEAAAVGAF |
| Q9P2E9 | S1122 | Sugiyama | RRBP1 KIAA1398 | APAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEGML |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.997825e-09 | 8.301 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.863833e-07 | 6.313 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.137109e-06 | 5.383 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.166088e-05 | 4.933 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.630882e-05 | 4.788 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.061621e-05 | 4.686 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.314097e-05 | 4.480 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.280320e-05 | 4.484 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.756137e-05 | 4.425 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.210088e-05 | 4.376 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.604230e-05 | 4.337 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.750274e-05 | 4.323 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.151856e-05 | 4.288 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.321179e-05 | 4.274 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.830938e-05 | 4.234 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.629386e-05 | 4.179 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.718852e-05 | 4.112 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.347910e-05 | 4.134 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.726949e-05 | 4.059 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.732126e-05 | 4.059 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.022513e-04 | 3.990 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.116857e-04 | 3.952 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.088700e-04 | 3.963 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.606887e-04 | 3.794 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.786137e-04 | 3.748 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.887980e-04 | 3.724 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.056890e-04 | 3.687 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.056890e-04 | 3.687 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.326834e-04 | 3.633 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.410985e-04 | 3.618 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.773987e-04 | 3.557 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.948269e-04 | 3.530 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.284814e-04 | 3.483 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.422073e-04 | 3.466 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.141353e-04 | 3.503 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.470411e-04 | 3.460 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.823252e-04 | 3.418 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.871808e-04 | 3.412 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.261411e-04 | 3.370 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.180901e-04 | 3.379 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.101722e-04 | 3.387 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.194773e-04 | 3.377 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.641793e-04 | 3.333 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.660649e-04 | 3.332 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.110723e-04 | 3.292 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.110723e-04 | 3.292 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.083812e-04 | 3.294 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.124344e-04 | 3.290 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.369958e-04 | 3.270 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.294768e-04 | 3.276 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.028005e-04 | 3.220 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.456547e-04 | 3.127 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.874925e-04 | 3.005 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.113687e-03 | 2.953 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.110709e-03 | 2.954 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110016e-03 | 2.955 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.113687e-03 | 2.953 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.392841e-03 | 2.856 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.469057e-03 | 2.833 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.469057e-03 | 2.833 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.490822e-03 | 2.827 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.545267e-03 | 2.811 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.644670e-03 | 2.784 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.612756e-03 | 2.792 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.717817e-03 | 2.765 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.751798e-03 | 2.757 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.751798e-03 | 2.757 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.751798e-03 | 2.757 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.751798e-03 | 2.757 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.694211e-03 | 2.771 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.751798e-03 | 2.757 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.756547e-03 | 2.755 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.883894e-03 | 2.725 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.906295e-03 | 2.720 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.049423e-03 | 2.688 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.078733e-03 | 2.682 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.101556e-03 | 2.677 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.109341e-03 | 2.676 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.251150e-03 | 2.648 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.330628e-03 | 2.633 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.479281e-03 | 2.606 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.446486e-03 | 2.611 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.559380e-03 | 2.592 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.769947e-03 | 2.558 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.820148e-03 | 2.550 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.836354e-03 | 2.547 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.008934e-03 | 2.522 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.008934e-03 | 2.522 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.075385e-03 | 2.512 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.386874e-03 | 2.470 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.708153e-03 | 2.431 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.511512e-03 | 2.455 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.685217e-03 | 2.434 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.681616e-03 | 2.434 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.511512e-03 | 2.455 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.601938e-03 | 2.443 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.681616e-03 | 2.434 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.681616e-03 | 2.434 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.547592e-03 | 2.450 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.653348e-03 | 2.437 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.769822e-03 | 2.424 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.853528e-03 | 2.414 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.943072e-03 | 2.404 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.943072e-03 | 2.404 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.944927e-03 | 2.404 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.005046e-03 | 2.397 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.190556e-03 | 2.378 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.190556e-03 | 2.378 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.315927e-03 | 2.365 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.204510e-03 | 2.376 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.542951e-03 | 2.343 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.782200e-03 | 2.320 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.989790e-03 | 2.302 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.168465e-03 | 2.287 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.321711e-03 | 2.274 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.373031e-03 | 2.270 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.392321e-03 | 2.268 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.447549e-03 | 2.264 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.601886e-03 | 2.252 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.815856e-03 | 2.235 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.070075e-03 | 2.217 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.639374e-03 | 2.178 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.082726e-03 | 2.216 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.086983e-03 | 2.216 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.155705e-03 | 2.211 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.801286e-03 | 2.167 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.810210e-03 | 2.167 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.872468e-03 | 2.163 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.092238e-03 | 2.149 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.271631e-03 | 2.138 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.271631e-03 | 2.138 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.288242e-03 | 2.137 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.552501e-03 | 2.068 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.560409e-03 | 2.068 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.971166e-03 | 2.047 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.398039e-03 | 2.027 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.008268e-03 | 2.045 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.540132e-03 | 2.020 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.907534e-03 | 2.004 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.679831e-03 | 2.014 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.480279e-03 | 2.023 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.913591e-03 | 2.004 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.052402e-02 | 1.978 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.100998e-02 | 1.958 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.121497e-02 | 1.950 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.125115e-02 | 1.949 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.125115e-02 | 1.949 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.208674e-02 | 1.918 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.260057e-02 | 1.900 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.303052e-02 | 1.885 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.476279e-02 | 1.831 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.476279e-02 | 1.831 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.476279e-02 | 1.831 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.476279e-02 | 1.831 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.476279e-02 | 1.831 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.476279e-02 | 1.831 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.407124e-02 | 1.852 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.315196e-02 | 1.881 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.315196e-02 | 1.881 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.459290e-02 | 1.836 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.462899e-02 | 1.835 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.437168e-02 | 1.842 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.462129e-02 | 1.835 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.395664e-02 | 1.855 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.543782e-02 | 1.811 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.571930e-02 | 1.804 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.656709e-02 | 1.781 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.656709e-02 | 1.781 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.679114e-02 | 1.775 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.697163e-02 | 1.770 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.824265e-02 | 1.739 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.824265e-02 | 1.739 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.824265e-02 | 1.739 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.824265e-02 | 1.739 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.862336e-02 | 1.730 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.920218e-02 | 1.717 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.034650e-02 | 1.692 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.169834e-02 | 1.664 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.922698e-02 | 1.716 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.922698e-02 | 1.716 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.083281e-02 | 1.681 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.902416e-02 | 1.721 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.105846e-02 | 1.677 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.216384e-02 | 1.654 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.371529e-02 | 1.625 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.509702e-02 | 1.600 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.535501e-02 | 1.596 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.535501e-02 | 1.596 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.540364e-02 | 1.595 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.543010e-02 | 1.595 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.552026e-02 | 1.593 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.552026e-02 | 1.593 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.606258e-02 | 1.584 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.606258e-02 | 1.584 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.606258e-02 | 1.584 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.700835e-02 | 1.569 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.700916e-02 | 1.568 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.711240e-02 | 1.567 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.711240e-02 | 1.567 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.741344e-02 | 1.562 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.129410e-02 | 1.505 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.129410e-02 | 1.505 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.129410e-02 | 1.505 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.256754e-02 | 1.487 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.176782e-02 | 1.498 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.902031e-02 | 1.537 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.902031e-02 | 1.537 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.954886e-02 | 1.529 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.256754e-02 | 1.487 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.256754e-02 | 1.487 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.895988e-02 | 1.538 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.129410e-02 | 1.505 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.008832e-02 | 1.522 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.811663e-02 | 1.551 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.362532e-02 | 1.473 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.397441e-02 | 1.469 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.403795e-02 | 1.468 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.614217e-02 | 1.442 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.707052e-02 | 1.431 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.707052e-02 | 1.431 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.789063e-02 | 1.421 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.789063e-02 | 1.421 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.789063e-02 | 1.421 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.819679e-02 | 1.418 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.877957e-02 | 1.411 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.884341e-02 | 1.411 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.884341e-02 | 1.411 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.923411e-02 | 1.406 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.957116e-02 | 1.403 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.957116e-02 | 1.403 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.957116e-02 | 1.403 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.957116e-02 | 1.403 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.957116e-02 | 1.403 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.060197e-02 | 1.391 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.086124e-02 | 1.389 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.052749e-02 | 1.296 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.017312e-02 | 1.300 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.052749e-02 | 1.296 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.049372e-02 | 1.297 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.763505e-02 | 1.322 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.536543e-02 | 1.343 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.052749e-02 | 1.296 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.536543e-02 | 1.343 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.572018e-02 | 1.340 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.474280e-02 | 1.349 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.959881e-02 | 1.305 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.894548e-02 | 1.310 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.658210e-02 | 1.332 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.536543e-02 | 1.343 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.572018e-02 | 1.340 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.226969e-02 | 1.282 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.243141e-02 | 1.280 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.243943e-02 | 1.280 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.243943e-02 | 1.280 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.243943e-02 | 1.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.243943e-02 | 1.280 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.243943e-02 | 1.280 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.253400e-02 | 1.280 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.423957e-02 | 1.266 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.427188e-02 | 1.265 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.705715e-02 | 1.244 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.773646e-02 | 1.239 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.971127e-02 | 1.224 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.070261e-02 | 1.217 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.070261e-02 | 1.217 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.195257e-02 | 1.208 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.302528e-02 | 1.200 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.302528e-02 | 1.200 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.326737e-02 | 1.199 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.326737e-02 | 1.199 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.361509e-02 | 1.196 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.361509e-02 | 1.196 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.449065e-02 | 1.191 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 7.726888e-02 | 1.112 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.726888e-02 | 1.112 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.726888e-02 | 1.112 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.493681e-02 | 1.188 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.493681e-02 | 1.188 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.493681e-02 | 1.188 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.100545e-02 | 1.091 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.100545e-02 | 1.091 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.222152e-02 | 1.141 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.137053e-02 | 1.146 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.137053e-02 | 1.146 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.735061e-02 | 1.112 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.912335e-02 | 1.160 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.537751e-02 | 1.185 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.537751e-02 | 1.185 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.902144e-02 | 1.102 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.493681e-02 | 1.188 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.100545e-02 | 1.091 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.005091e-02 | 1.155 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.222152e-02 | 1.141 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.756264e-02 | 1.170 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.735061e-02 | 1.112 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.879573e-02 | 1.103 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.687020e-02 | 1.114 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.979187e-02 | 1.156 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.052293e-02 | 1.152 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.687020e-02 | 1.114 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.687020e-02 | 1.114 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.979187e-02 | 1.156 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.152768e-02 | 1.089 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.152768e-02 | 1.089 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.152768e-02 | 1.089 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.158725e-02 | 1.088 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.407338e-02 | 1.075 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.497432e-02 | 1.071 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.497432e-02 | 1.071 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.536808e-02 | 1.069 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.648770e-02 | 1.063 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.724718e-02 | 1.059 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.724718e-02 | 1.059 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.891759e-02 | 1.051 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.995289e-02 | 1.046 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.240919e-02 | 1.034 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.384103e-02 | 1.028 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.452349e-02 | 1.024 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.624161e-02 | 1.017 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 9.829687e-02 | 1.007 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.829687e-02 | 1.007 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.829687e-02 | 1.007 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.829687e-02 | 1.007 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.854166e-02 | 1.006 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.860106e-02 | 1.006 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.860106e-02 | 1.006 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 9.860106e-02 | 1.006 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.860106e-02 | 1.006 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.927565e-02 | 1.003 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.962585e-02 | 1.002 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.001662e-01 | 0.999 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.046222e-01 | 0.980 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.046222e-01 | 0.980 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.047518e-01 | 0.980 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.049795e-01 | 0.979 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.049795e-01 | 0.979 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.049795e-01 | 0.979 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.049795e-01 | 0.979 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.049795e-01 | 0.979 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.076251e-01 | 0.968 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.079687e-01 | 0.967 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.080245e-01 | 0.966 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.111457e-01 | 0.954 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.111457e-01 | 0.954 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.121301e-01 | 0.950 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.121301e-01 | 0.950 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.348804e-01 | 0.870 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.348804e-01 | 0.870 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.348804e-01 | 0.870 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.348804e-01 | 0.870 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.377852e-01 | 0.861 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.281025e-01 | 0.892 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.162610e-01 | 0.935 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.427141e-01 | 0.846 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.264126e-01 | 0.898 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.427843e-01 | 0.845 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.427843e-01 | 0.845 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.257614e-01 | 0.900 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.351967e-01 | 0.869 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.449795e-01 | 0.839 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.283043e-01 | 0.892 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.438905e-01 | 0.842 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.262949e-01 | 0.899 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 1.442583e-01 | 0.841 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.502086e-01 | 0.823 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.329468e-01 | 0.876 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.377852e-01 | 0.861 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.201481e-01 | 0.920 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.348804e-01 | 0.870 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.285255e-01 | 0.891 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.152572e-01 | 0.938 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.291781e-01 | 0.889 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.208761e-01 | 0.918 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.387650e-01 | 0.858 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.144765e-01 | 0.941 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.129197e-01 | 0.947 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.348804e-01 | 0.870 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.127611e-01 | 0.948 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.129197e-01 | 0.947 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.184673e-01 | 0.926 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.155890e-01 | 0.937 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.502086e-01 | 0.823 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.291781e-01 | 0.889 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.502086e-01 | 0.823 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.438087e-01 | 0.842 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.281025e-01 | 0.892 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.455682e-01 | 0.837 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.446643e-01 | 0.840 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.127611e-01 | 0.948 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.516500e-01 | 0.819 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.527275e-01 | 0.816 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.550996e-01 | 0.809 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.550996e-01 | 0.809 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.550996e-01 | 0.809 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.568334e-01 | 0.805 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.568334e-01 | 0.805 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.568334e-01 | 0.805 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.590652e-01 | 0.798 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.590652e-01 | 0.798 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.590652e-01 | 0.798 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.611615e-01 | 0.793 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.615544e-01 | 0.792 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.628057e-01 | 0.788 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.645745e-01 | 0.784 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.645745e-01 | 0.784 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.652203e-01 | 0.782 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.652203e-01 | 0.782 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.652203e-01 | 0.782 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.655456e-01 | 0.781 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.657850e-01 | 0.780 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.663789e-01 | 0.779 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.663789e-01 | 0.779 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.663789e-01 | 0.779 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.663789e-01 | 0.779 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.663789e-01 | 0.779 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.663789e-01 | 0.779 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.663789e-01 | 0.779 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.668870e-01 | 0.778 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.668870e-01 | 0.778 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.668870e-01 | 0.778 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.668870e-01 | 0.778 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.668870e-01 | 0.778 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.395824e-01 | 0.621 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.395824e-01 | 0.621 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.395824e-01 | 0.621 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.395824e-01 | 0.621 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.395824e-01 | 0.621 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.989693e-01 | 0.701 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.989693e-01 | 0.701 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.322215e-01 | 0.634 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.322215e-01 | 0.634 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.812628e-01 | 0.742 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.812628e-01 | 0.742 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.812628e-01 | 0.742 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.812628e-01 | 0.742 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.812628e-01 | 0.742 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.812628e-01 | 0.742 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.812628e-01 | 0.742 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.812628e-01 | 0.742 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.042250e-01 | 0.690 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.787420e-01 | 0.748 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.787420e-01 | 0.748 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.278040e-01 | 0.642 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.969278e-01 | 0.706 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.969278e-01 | 0.706 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.969278e-01 | 0.706 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.969278e-01 | 0.706 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.969278e-01 | 0.706 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.969278e-01 | 0.706 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.518581e-01 | 0.599 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.518581e-01 | 0.599 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.156456e-01 | 0.666 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.183518e-01 | 0.661 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.891069e-01 | 0.723 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.744976e-01 | 0.758 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.142945e-01 | 0.669 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.465420e-01 | 0.608 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.406185e-01 | 0.619 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.222000e-01 | 0.653 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.343120e-01 | 0.630 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.946103e-01 | 0.711 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.814425e-01 | 0.741 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.347792e-01 | 0.629 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.866674e-01 | 0.729 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.744976e-01 | 0.758 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.969278e-01 | 0.706 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.427344e-01 | 0.615 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.969278e-01 | 0.706 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.348223e-01 | 0.629 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.714980e-01 | 0.766 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.030943e-01 | 0.692 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.030943e-01 | 0.692 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.183518e-01 | 0.661 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.515374e-01 | 0.599 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.866674e-01 | 0.729 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.322215e-01 | 0.634 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.787420e-01 | 0.748 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.518581e-01 | 0.599 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.983287e-01 | 0.703 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.030943e-01 | 0.692 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.989693e-01 | 0.701 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.278040e-01 | 0.642 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.714980e-01 | 0.766 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.246468e-01 | 0.648 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.969278e-01 | 0.706 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.030943e-01 | 0.692 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.030943e-01 | 0.692 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.142945e-01 | 0.669 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.222000e-01 | 0.653 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.109313e-01 | 0.676 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.812628e-01 | 0.742 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.347792e-01 | 0.629 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.969278e-01 | 0.706 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.518581e-01 | 0.599 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.395824e-01 | 0.621 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.518581e-01 | 0.599 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.465420e-01 | 0.608 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.103274e-01 | 0.677 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.058244e-01 | 0.687 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.058244e-01 | 0.687 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.023745e-01 | 0.694 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.084943e-01 | 0.681 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.518581e-01 | 0.599 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.866674e-01 | 0.729 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.891069e-01 | 0.723 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.234951e-01 | 0.651 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.314860e-01 | 0.635 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.022998e-01 | 0.694 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.105878e-01 | 0.677 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.395824e-01 | 0.621 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.518581e-01 | 0.599 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.518581e-01 | 0.599 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.250309e-01 | 0.648 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.215006e-01 | 0.655 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.014826e-01 | 0.696 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.322215e-01 | 0.634 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.513327e-01 | 0.600 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.015480e-01 | 0.696 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.936213e-01 | 0.713 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.030943e-01 | 0.692 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.866674e-01 | 0.729 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.740610e-01 | 0.759 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.541523e-01 | 0.595 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.543852e-01 | 0.595 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.569485e-01 | 0.590 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.584217e-01 | 0.588 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.059385e-01 | 0.514 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.059385e-01 | 0.514 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.059385e-01 | 0.514 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.059385e-01 | 0.514 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.059385e-01 | 0.514 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.059385e-01 | 0.514 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.059385e-01 | 0.514 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.059385e-01 | 0.514 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.665078e-01 | 0.436 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.665078e-01 | 0.436 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.665078e-01 | 0.436 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.665078e-01 | 0.436 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.665078e-01 | 0.436 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.657723e-01 | 0.575 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.993167e-01 | 0.524 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.993167e-01 | 0.524 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.993167e-01 | 0.524 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.993167e-01 | 0.524 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.993167e-01 | 0.524 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.217946e-01 | 0.375 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.762538e-01 | 0.559 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.762538e-01 | 0.559 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.762538e-01 | 0.559 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.654142e-01 | 0.437 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.654142e-01 | 0.437 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.654142e-01 | 0.437 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.654142e-01 | 0.437 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.654142e-01 | 0.437 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.722593e-01 | 0.326 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.722593e-01 | 0.326 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.722593e-01 | 0.326 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.722593e-01 | 0.326 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.722593e-01 | 0.326 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.722593e-01 | 0.326 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.255774e-01 | 0.487 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.975862e-01 | 0.401 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 3.975862e-01 | 0.401 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.975862e-01 | 0.401 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.502822e-01 | 0.456 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.146866e-01 | 0.502 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.615881e-01 | 0.582 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.615881e-01 | 0.582 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.615881e-01 | 0.582 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.033517e-01 | 0.518 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.748823e-01 | 0.426 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.289789e-01 | 0.368 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.289789e-01 | 0.368 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.591871e-01 | 0.586 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.555674e-01 | 0.449 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.594833e-01 | 0.338 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.594833e-01 | 0.338 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.594833e-01 | 0.338 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.594833e-01 | 0.338 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.102385e-01 | 0.508 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.565638e-01 | 0.448 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.978667e-01 | 0.526 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.246331e-01 | 0.489 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.537104e-01 | 0.451 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.167140e-01 | 0.380 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.167140e-01 | 0.380 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.472162e-01 | 0.349 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.890155e-01 | 0.311 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.890155e-01 | 0.311 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.706034e-01 | 0.327 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.706034e-01 | 0.327 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.693748e-01 | 0.433 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.175127e-01 | 0.286 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.175127e-01 | 0.286 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.175127e-01 | 0.286 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.356909e-01 | 0.361 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.935319e-01 | 0.307 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.159552e-01 | 0.287 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.829727e-01 | 0.316 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.829727e-01 | 0.316 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.984714e-01 | 0.302 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.132729e-01 | 0.290 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.393278e-01 | 0.469 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.986372e-01 | 0.525 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.986372e-01 | 0.525 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.719157e-01 | 0.566 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.167140e-01 | 0.380 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.017844e-01 | 0.299 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.858678e-01 | 0.544 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.739274e-01 | 0.562 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.758497e-01 | 0.323 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.278081e-01 | 0.369 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.783811e-01 | 0.422 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.766821e-01 | 0.558 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.512420e-01 | 0.454 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.040758e-01 | 0.517 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.377588e-01 | 0.471 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.629164e-01 | 0.334 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.149353e-01 | 0.288 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.336554e-01 | 0.477 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.986372e-01 | 0.525 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.297677e-01 | 0.367 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.567658e-01 | 0.340 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.326006e-01 | 0.478 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.764466e-01 | 0.322 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.159552e-01 | 0.287 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.806949e-01 | 0.318 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.502822e-01 | 0.456 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.762538e-01 | 0.559 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 3.654142e-01 | 0.437 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.706034e-01 | 0.327 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.110533e-01 | 0.507 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.124210e-01 | 0.505 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.629164e-01 | 0.334 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.149353e-01 | 0.288 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.615881e-01 | 0.582 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.657723e-01 | 0.575 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.722593e-01 | 0.326 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.615881e-01 | 0.582 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.959702e-01 | 0.529 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.935319e-01 | 0.307 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.762538e-01 | 0.559 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.102143e-01 | 0.508 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 4.436444e-01 | 0.353 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.562376e-01 | 0.341 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.905410e-01 | 0.309 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.905410e-01 | 0.309 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.923409e-01 | 0.534 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.657723e-01 | 0.575 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.008656e-01 | 0.522 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.654142e-01 | 0.437 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 2.742628e-01 | 0.562 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.748823e-01 | 0.426 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.890155e-01 | 0.311 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.802338e-01 | 0.319 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.149353e-01 | 0.288 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.537104e-01 | 0.451 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.625157e-01 | 0.581 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.260442e-01 | 0.371 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.102385e-01 | 0.508 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.567658e-01 | 0.340 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.594833e-01 | 0.338 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.126191e-01 | 0.505 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.255774e-01 | 0.487 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.555674e-01 | 0.449 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.992893e-01 | 0.399 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.922683e-01 | 0.406 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.764466e-01 | 0.322 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.764466e-01 | 0.322 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.978667e-01 | 0.526 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.550324e-01 | 0.450 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.109440e-01 | 0.507 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.387411e-01 | 0.470 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.289789e-01 | 0.368 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.748823e-01 | 0.426 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.368416e-01 | 0.360 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.749646e-01 | 0.561 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.079860e-01 | 0.511 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.071974e-01 | 0.513 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.714253e-01 | 0.566 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.059385e-01 | 0.514 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.059385e-01 | 0.514 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.059385e-01 | 0.514 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.059385e-01 | 0.514 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.059385e-01 | 0.514 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 3.665078e-01 | 0.436 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.657723e-01 | 0.575 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.326006e-01 | 0.478 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.762538e-01 | 0.559 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.008656e-01 | 0.522 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.654142e-01 | 0.437 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.722593e-01 | 0.326 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.943857e-01 | 0.531 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.975862e-01 | 0.401 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.502822e-01 | 0.456 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.146866e-01 | 0.502 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.594833e-01 | 0.338 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.594833e-01 | 0.338 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.368416e-01 | 0.360 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.912610e-01 | 0.536 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.037336e-01 | 0.394 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.149353e-01 | 0.288 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.599697e-01 | 0.337 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.783811e-01 | 0.422 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.943857e-01 | 0.531 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.943857e-01 | 0.531 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.175127e-01 | 0.286 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.993556e-01 | 0.302 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.246331e-01 | 0.489 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.336389e-01 | 0.363 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.208307e-01 | 0.494 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.882392e-01 | 0.311 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.806949e-01 | 0.318 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.454996e-01 | 0.462 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.555674e-01 | 0.449 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.965652e-01 | 0.528 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.683485e-01 | 0.434 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.484607e-01 | 0.458 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.993167e-01 | 0.524 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.217946e-01 | 0.375 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.722593e-01 | 0.326 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.289789e-01 | 0.368 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.289789e-01 | 0.368 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.289789e-01 | 0.368 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.890155e-01 | 0.311 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.890155e-01 | 0.311 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.706034e-01 | 0.327 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.175127e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.175127e-01 | 0.286 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.192506e-01 | 0.496 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.351010e-01 | 0.475 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.289789e-01 | 0.368 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.167140e-01 | 0.380 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.255774e-01 | 0.487 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.368416e-01 | 0.360 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.228471e-01 | 0.374 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.146866e-01 | 0.502 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.377588e-01 | 0.471 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.579135e-01 | 0.339 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.993167e-01 | 0.524 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.993167e-01 | 0.524 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.217946e-01 | 0.375 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.326006e-01 | 0.478 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.722593e-01 | 0.326 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.858678e-01 | 0.544 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.234241e-01 | 0.373 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.234241e-01 | 0.373 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.233302e-01 | 0.490 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.562376e-01 | 0.341 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.159552e-01 | 0.287 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.000917e-01 | 0.301 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.851303e-01 | 0.545 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.878320e-01 | 0.411 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.289789e-01 | 0.368 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.234241e-01 | 0.373 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.876957e-01 | 0.412 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.599697e-01 | 0.337 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.657723e-01 | 0.575 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.890155e-01 | 0.311 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.454316e-01 | 0.351 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.555674e-01 | 0.449 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.742628e-01 | 0.562 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.255774e-01 | 0.487 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.149353e-01 | 0.288 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.871835e-01 | 0.542 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.217946e-01 | 0.375 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.764466e-01 | 0.322 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.664936e-01 | 0.331 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.868056e-01 | 0.313 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.146866e-01 | 0.502 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.396614e-01 | 0.469 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.477313e-01 | 0.349 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.802338e-01 | 0.319 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.654142e-01 | 0.437 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.890155e-01 | 0.311 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.175127e-01 | 0.286 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.175127e-01 | 0.286 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.959734e-01 | 0.529 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.552260e-01 | 0.449 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.959734e-01 | 0.529 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.175127e-01 | 0.286 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.861623e-01 | 0.413 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.656492e-01 | 0.332 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.021824e-01 | 0.396 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.472162e-01 | 0.349 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.890155e-01 | 0.311 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.654142e-01 | 0.437 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.296004e-01 | 0.367 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.289789e-01 | 0.368 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.722593e-01 | 0.326 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.136568e-01 | 0.504 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.175127e-01 | 0.286 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.168773e-01 | 0.287 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.149353e-01 | 0.288 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.183224e-01 | 0.285 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.183224e-01 | 0.285 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.183224e-01 | 0.285 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.183224e-01 | 0.285 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.183224e-01 | 0.285 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.183224e-01 | 0.285 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.183224e-01 | 0.285 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.183224e-01 | 0.285 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.183224e-01 | 0.285 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.183224e-01 | 0.285 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.183224e-01 | 0.285 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.183224e-01 | 0.285 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.183224e-01 | 0.285 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.183224e-01 | 0.285 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.219562e-01 | 0.282 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.263371e-01 | 0.279 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.274839e-01 | 0.278 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.289602e-01 | 0.277 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.309275e-01 | 0.275 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.309275e-01 | 0.275 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.313309e-01 | 0.275 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.336811e-01 | 0.273 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.336811e-01 | 0.273 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.336811e-01 | 0.273 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.336811e-01 | 0.273 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.378339e-01 | 0.269 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.412844e-01 | 0.267 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.413196e-01 | 0.267 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.439160e-01 | 0.264 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.449307e-01 | 0.264 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.449307e-01 | 0.264 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.449307e-01 | 0.264 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.473309e-01 | 0.262 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.496907e-01 | 0.260 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.520587e-01 | 0.258 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.520587e-01 | 0.258 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.539550e-01 | 0.257 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.549894e-01 | 0.256 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.586586e-01 | 0.253 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.591351e-01 | 0.252 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.591351e-01 | 0.252 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.591351e-01 | 0.252 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.603673e-01 | 0.252 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.603673e-01 | 0.252 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.603673e-01 | 0.252 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.603673e-01 | 0.252 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.603673e-01 | 0.252 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.603673e-01 | 0.252 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.603673e-01 | 0.252 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.603673e-01 | 0.252 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.603673e-01 | 0.252 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.603673e-01 | 0.252 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.603673e-01 | 0.252 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.647165e-01 | 0.248 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.647165e-01 | 0.248 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.700452e-01 | 0.244 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.712409e-01 | 0.243 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.712409e-01 | 0.243 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.712409e-01 | 0.243 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 5.712409e-01 | 0.243 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.713307e-01 | 0.243 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.798323e-01 | 0.237 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.798323e-01 | 0.237 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.811796e-01 | 0.236 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.872363e-01 | 0.231 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.876210e-01 | 0.231 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.876210e-01 | 0.231 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.895253e-01 | 0.229 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.948524e-01 | 0.226 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.964276e-01 | 0.224 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.964276e-01 | 0.224 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.964276e-01 | 0.224 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.964276e-01 | 0.224 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.964276e-01 | 0.224 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.987445e-01 | 0.223 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.987445e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.987445e-01 | 0.223 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.987445e-01 | 0.223 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.987445e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.987445e-01 | 0.223 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.987445e-01 | 0.223 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.987445e-01 | 0.223 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.987445e-01 | 0.223 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.987445e-01 | 0.223 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.987445e-01 | 0.223 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.987445e-01 | 0.223 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.987445e-01 | 0.223 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.987445e-01 | 0.223 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.987445e-01 | 0.223 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.999044e-01 | 0.222 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.999044e-01 | 0.222 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.999044e-01 | 0.222 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.999044e-01 | 0.222 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.016700e-01 | 0.221 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.032696e-01 | 0.219 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.047695e-01 | 0.218 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.072945e-01 | 0.217 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.183571e-01 | 0.209 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.193355e-01 | 0.208 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.193355e-01 | 0.208 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.193355e-01 | 0.208 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.193355e-01 | 0.208 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.203886e-01 | 0.207 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.204866e-01 | 0.207 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.204866e-01 | 0.207 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.204866e-01 | 0.207 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.204866e-01 | 0.207 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.204866e-01 | 0.207 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.214765e-01 | 0.207 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.214765e-01 | 0.207 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.245511e-01 | 0.204 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.248459e-01 | 0.204 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.249779e-01 | 0.204 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.249779e-01 | 0.204 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.249779e-01 | 0.204 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.260206e-01 | 0.203 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.287278e-01 | 0.202 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.337737e-01 | 0.198 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.337737e-01 | 0.198 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.337737e-01 | 0.198 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.337737e-01 | 0.198 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.337737e-01 | 0.198 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.337737e-01 | 0.198 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.337737e-01 | 0.198 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.337737e-01 | 0.198 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.337737e-01 | 0.198 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.381143e-01 | 0.195 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.381143e-01 | 0.195 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.393570e-01 | 0.194 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.419404e-01 | 0.193 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.434227e-01 | 0.192 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.434227e-01 | 0.192 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.434227e-01 | 0.192 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.434227e-01 | 0.192 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.434227e-01 | 0.192 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.450153e-01 | 0.190 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.451569e-01 | 0.190 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.482165e-01 | 0.188 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.492647e-01 | 0.188 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.535148e-01 | 0.185 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.550364e-01 | 0.184 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.562339e-01 | 0.183 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.562339e-01 | 0.183 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.562339e-01 | 0.183 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.562339e-01 | 0.183 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.571011e-01 | 0.182 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.595119e-01 | 0.181 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.652487e-01 | 0.177 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.652487e-01 | 0.177 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.652487e-01 | 0.177 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.652487e-01 | 0.177 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.652663e-01 | 0.177 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.657468e-01 | 0.177 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.657468e-01 | 0.177 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.657468e-01 | 0.177 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.657468e-01 | 0.177 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.657468e-01 | 0.177 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.657468e-01 | 0.177 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.657468e-01 | 0.177 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.657468e-01 | 0.177 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.657468e-01 | 0.177 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.657468e-01 | 0.177 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.657468e-01 | 0.177 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.657468e-01 | 0.177 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.665409e-01 | 0.176 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.684917e-01 | 0.175 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.686816e-01 | 0.175 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.736910e-01 | 0.172 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.750362e-01 | 0.171 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.750362e-01 | 0.171 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.801422e-01 | 0.167 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.801422e-01 | 0.167 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.837011e-01 | 0.165 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.859835e-01 | 0.164 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.859835e-01 | 0.164 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.859835e-01 | 0.164 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.890119e-01 | 0.162 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.904858e-01 | 0.161 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.904858e-01 | 0.161 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.917170e-01 | 0.160 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.938100e-01 | 0.159 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.949302e-01 | 0.158 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.949302e-01 | 0.158 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.949302e-01 | 0.158 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.949302e-01 | 0.158 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 6.949302e-01 | 0.158 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.949302e-01 | 0.158 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.949302e-01 | 0.158 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.949302e-01 | 0.158 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.949302e-01 | 0.158 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.949302e-01 | 0.158 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.949302e-01 | 0.158 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.949302e-01 | 0.158 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.949302e-01 | 0.158 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.949302e-01 | 0.158 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.949302e-01 | 0.158 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.949302e-01 | 0.158 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.980786e-01 | 0.156 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.980786e-01 | 0.156 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.056512e-01 | 0.151 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.056512e-01 | 0.151 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.066216e-01 | 0.151 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.119805e-01 | 0.148 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.150400e-01 | 0.146 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.150400e-01 | 0.146 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.150400e-01 | 0.146 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.212934e-01 | 0.142 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.215672e-01 | 0.142 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.215672e-01 | 0.142 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.215672e-01 | 0.142 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.215672e-01 | 0.142 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.215672e-01 | 0.142 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.215672e-01 | 0.142 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.215672e-01 | 0.142 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.215672e-01 | 0.142 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.215672e-01 | 0.142 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.215672e-01 | 0.142 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.215672e-01 | 0.142 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.221043e-01 | 0.141 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.221043e-01 | 0.141 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.221043e-01 | 0.141 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.221043e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.242801e-01 | 0.140 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.242801e-01 | 0.140 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.242801e-01 | 0.140 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.242801e-01 | 0.140 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.242801e-01 | 0.140 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.242801e-01 | 0.140 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.254080e-01 | 0.139 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.254080e-01 | 0.139 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.254080e-01 | 0.139 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.261608e-01 | 0.139 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.307703e-01 | 0.136 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.369422e-01 | 0.133 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.383634e-01 | 0.132 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.404323e-01 | 0.131 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.419017e-01 | 0.130 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.419017e-01 | 0.130 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.419017e-01 | 0.130 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.423453e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.423453e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.423453e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.423453e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.423453e-01 | 0.129 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.423453e-01 | 0.129 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.434959e-01 | 0.129 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.458799e-01 | 0.127 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.458799e-01 | 0.127 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.458799e-01 | 0.127 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.458799e-01 | 0.127 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.458799e-01 | 0.127 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.458799e-01 | 0.127 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.458799e-01 | 0.127 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.458799e-01 | 0.127 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.458799e-01 | 0.127 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.458799e-01 | 0.127 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.458799e-01 | 0.127 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.462404e-01 | 0.127 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.480922e-01 | 0.126 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.508507e-01 | 0.124 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.511454e-01 | 0.124 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.511454e-01 | 0.124 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.511454e-01 | 0.124 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.511454e-01 | 0.124 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.535498e-01 | 0.123 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.535498e-01 | 0.123 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.536161e-01 | 0.123 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.576777e-01 | 0.121 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.585497e-01 | 0.120 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.585497e-01 | 0.120 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.585497e-01 | 0.120 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.585497e-01 | 0.120 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 7.585497e-01 | 0.120 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.643864e-01 | 0.117 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.647260e-01 | 0.116 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.675709e-01 | 0.115 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.677150e-01 | 0.115 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.679521e-01 | 0.115 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.680709e-01 | 0.115 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.680709e-01 | 0.115 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.680709e-01 | 0.115 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.680709e-01 | 0.115 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.680709e-01 | 0.115 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.680709e-01 | 0.115 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.680709e-01 | 0.115 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.680709e-01 | 0.115 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.680709e-01 | 0.115 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.692728e-01 | 0.114 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.742597e-01 | 0.111 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.742597e-01 | 0.111 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.742597e-01 | 0.111 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.776975e-01 | 0.109 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.776975e-01 | 0.109 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.844310e-01 | 0.105 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.855609e-01 | 0.105 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.858757e-01 | 0.105 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.858757e-01 | 0.105 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.883253e-01 | 0.103 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.883253e-01 | 0.103 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.883253e-01 | 0.103 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.883253e-01 | 0.103 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.883253e-01 | 0.103 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.883253e-01 | 0.103 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.883253e-01 | 0.103 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.883253e-01 | 0.103 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.883253e-01 | 0.103 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.890686e-01 | 0.103 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.890686e-01 | 0.103 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.900746e-01 | 0.102 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.900746e-01 | 0.102 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.900746e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.900746e-01 | 0.102 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.924495e-01 | 0.101 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.954411e-01 | 0.099 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.962374e-01 | 0.099 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.969875e-01 | 0.099 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.978034e-01 | 0.098 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.002438e-01 | 0.097 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.018731e-01 | 0.096 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.018731e-01 | 0.096 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.018731e-01 | 0.096 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.030140e-01 | 0.095 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.030140e-01 | 0.095 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.030140e-01 | 0.095 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.030140e-01 | 0.095 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.030140e-01 | 0.095 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.030140e-01 | 0.095 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.042062e-01 | 0.095 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.068119e-01 | 0.093 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.068119e-01 | 0.093 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.068119e-01 | 0.093 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.068119e-01 | 0.093 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.068119e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.068119e-01 | 0.093 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.068119e-01 | 0.093 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.125454e-01 | 0.090 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.131096e-01 | 0.090 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.131096e-01 | 0.090 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.131096e-01 | 0.090 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.131096e-01 | 0.090 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.161336e-01 | 0.088 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.161336e-01 | 0.088 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.163019e-01 | 0.088 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.209841e-01 | 0.086 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.224637e-01 | 0.085 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.236851e-01 | 0.084 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.236851e-01 | 0.084 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.236851e-01 | 0.084 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.236851e-01 | 0.084 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.236851e-01 | 0.084 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.236851e-01 | 0.084 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.238013e-01 | 0.084 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.238013e-01 | 0.084 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.242809e-01 | 0.084 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.284653e-01 | 0.082 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.284653e-01 | 0.082 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.284653e-01 | 0.082 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.284653e-01 | 0.082 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.284653e-01 | 0.082 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.339658e-01 | 0.079 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.339658e-01 | 0.079 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.339658e-01 | 0.079 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.347135e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.347135e-01 | 0.078 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.347135e-01 | 0.078 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.354490e-01 | 0.078 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.383679e-01 | 0.077 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.383679e-01 | 0.077 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.384944e-01 | 0.076 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.390854e-01 | 0.076 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.390854e-01 | 0.076 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.390854e-01 | 0.076 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.390854e-01 | 0.076 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.390854e-01 | 0.076 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.390854e-01 | 0.076 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.390854e-01 | 0.076 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.390854e-01 | 0.076 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.390854e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.390854e-01 | 0.076 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.390854e-01 | 0.076 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.405673e-01 | 0.075 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.436214e-01 | 0.074 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.461162e-01 | 0.073 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.487229e-01 | 0.071 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.489700e-01 | 0.071 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.509144e-01 | 0.070 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.512888e-01 | 0.070 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.515569e-01 | 0.070 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.527861e-01 | 0.069 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.527861e-01 | 0.069 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.527861e-01 | 0.069 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.531414e-01 | 0.069 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.531414e-01 | 0.069 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.531414e-01 | 0.069 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.531414e-01 | 0.069 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.531414e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.531414e-01 | 0.069 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.531414e-01 | 0.069 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.531414e-01 | 0.069 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.535547e-01 | 0.069 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.571581e-01 | 0.067 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.594184e-01 | 0.066 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.611050e-01 | 0.065 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.611050e-01 | 0.065 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.614783e-01 | 0.065 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.614783e-01 | 0.065 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.614783e-01 | 0.065 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.614783e-01 | 0.065 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.614783e-01 | 0.065 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.614783e-01 | 0.065 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.636716e-01 | 0.064 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.659704e-01 | 0.062 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.659704e-01 | 0.062 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.659704e-01 | 0.062 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.659704e-01 | 0.062 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.669217e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.675564e-01 | 0.062 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.697165e-01 | 0.061 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.699371e-01 | 0.061 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.706538e-01 | 0.060 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.731326e-01 | 0.059 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.776241e-01 | 0.057 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.776241e-01 | 0.057 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.776794e-01 | 0.057 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.776794e-01 | 0.057 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.776794e-01 | 0.057 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.776794e-01 | 0.057 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.776794e-01 | 0.057 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.795951e-01 | 0.056 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.795951e-01 | 0.056 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.795951e-01 | 0.056 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.808999e-01 | 0.055 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.814197e-01 | 0.055 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.823686e-01 | 0.054 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.842197e-01 | 0.053 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.849030e-01 | 0.053 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.873069e-01 | 0.052 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.873981e-01 | 0.052 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.879621e-01 | 0.052 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.879621e-01 | 0.052 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.879621e-01 | 0.052 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.879621e-01 | 0.052 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.879621e-01 | 0.052 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.883661e-01 | 0.051 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.883661e-01 | 0.051 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.883661e-01 | 0.051 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 8.883661e-01 | 0.051 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.883661e-01 | 0.051 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.918873e-01 | 0.050 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.918873e-01 | 0.050 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.935843e-01 | 0.049 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.957868e-01 | 0.048 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.957868e-01 | 0.048 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.957868e-01 | 0.048 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.972730e-01 | 0.047 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.977608e-01 | 0.047 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.981197e-01 | 0.047 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.981197e-01 | 0.047 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.981197e-01 | 0.047 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.981197e-01 | 0.047 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.995458e-01 | 0.046 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.026247e-01 | 0.044 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.026688e-01 | 0.044 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.026688e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.028786e-01 | 0.044 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.028786e-01 | 0.044 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.031002e-01 | 0.044 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.031002e-01 | 0.044 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.031002e-01 | 0.044 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.031002e-01 | 0.044 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.032820e-01 | 0.044 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.036754e-01 | 0.044 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.036968e-01 | 0.044 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.047253e-01 | 0.043 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.065079e-01 | 0.043 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.065079e-01 | 0.043 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.065079e-01 | 0.043 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.070217e-01 | 0.042 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.070217e-01 | 0.042 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.070217e-01 | 0.042 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.070217e-01 | 0.042 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.070217e-01 | 0.042 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.070217e-01 | 0.042 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.070217e-01 | 0.042 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.070217e-01 | 0.042 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.070217e-01 | 0.042 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.073728e-01 | 0.042 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.099318e-01 | 0.041 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.099318e-01 | 0.041 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.099318e-01 | 0.041 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.099318e-01 | 0.041 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.099318e-01 | 0.041 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.099318e-01 | 0.041 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.102605e-01 | 0.041 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.103860e-01 | 0.041 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.106130e-01 | 0.041 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.106130e-01 | 0.041 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.151463e-01 | 0.039 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.151463e-01 | 0.039 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.151463e-01 | 0.039 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.151463e-01 | 0.039 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.161938e-01 | 0.038 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.161938e-01 | 0.038 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.163100e-01 | 0.038 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.164039e-01 | 0.038 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.173603e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.173603e-01 | 0.037 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.214071e-01 | 0.036 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.214264e-01 | 0.036 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.222617e-01 | 0.035 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.222617e-01 | 0.035 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.225614e-01 | 0.035 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.225614e-01 | 0.035 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.225614e-01 | 0.035 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.263448e-01 | 0.033 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.263448e-01 | 0.033 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.278129e-01 | 0.033 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.278129e-01 | 0.033 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.278129e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.279614e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.279614e-01 | 0.032 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.293290e-01 | 0.032 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.293290e-01 | 0.032 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.293290e-01 | 0.032 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.293290e-01 | 0.032 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.293290e-01 | 0.032 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.293290e-01 | 0.032 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.293290e-01 | 0.032 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.312228e-01 | 0.031 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.316611e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.316611e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.316611e-01 | 0.031 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.329880e-01 | 0.030 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.329880e-01 | 0.030 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.329880e-01 | 0.030 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.355054e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.355054e-01 | 0.029 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.355054e-01 | 0.029 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.355054e-01 | 0.029 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.355054e-01 | 0.029 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.355054e-01 | 0.029 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.359434e-01 | 0.029 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.374821e-01 | 0.028 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.378103e-01 | 0.028 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.378103e-01 | 0.028 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.378103e-01 | 0.028 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.378103e-01 | 0.028 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.407386e-01 | 0.027 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.411424e-01 | 0.026 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.411424e-01 | 0.026 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.411424e-01 | 0.026 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.411424e-01 | 0.026 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.411424e-01 | 0.026 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.411424e-01 | 0.026 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.433750e-01 | 0.025 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.442130e-01 | 0.025 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.442130e-01 | 0.025 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.458739e-01 | 0.024 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.462871e-01 | 0.024 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.462871e-01 | 0.024 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.462871e-01 | 0.024 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.462871e-01 | 0.024 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.462871e-01 | 0.024 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.462871e-01 | 0.024 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.464840e-01 | 0.024 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.485358e-01 | 0.023 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.501377e-01 | 0.022 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.503761e-01 | 0.022 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.503761e-01 | 0.022 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.503761e-01 | 0.022 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.504465e-01 | 0.022 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.504465e-01 | 0.022 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.506092e-01 | 0.022 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.509823e-01 | 0.022 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.509823e-01 | 0.022 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.509823e-01 | 0.022 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.509823e-01 | 0.022 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.509823e-01 | 0.022 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.536650e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.539970e-01 | 0.020 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.539970e-01 | 0.020 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.552673e-01 | 0.020 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.552673e-01 | 0.020 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.552673e-01 | 0.020 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.552673e-01 | 0.020 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.573643e-01 | 0.019 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.591780e-01 | 0.018 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.591780e-01 | 0.018 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.600336e-01 | 0.018 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.607331e-01 | 0.017 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.614249e-01 | 0.017 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.619564e-01 | 0.017 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.619564e-01 | 0.017 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.619564e-01 | 0.017 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.619564e-01 | 0.017 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.626870e-01 | 0.017 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.627470e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.627470e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.634040e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.634040e-01 | 0.016 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.639894e-01 | 0.016 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.657827e-01 | 0.015 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.661068e-01 | 0.015 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.663309e-01 | 0.015 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.686169e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.686169e-01 | 0.014 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.709474e-01 | 0.013 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.716896e-01 | 0.012 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.716896e-01 | 0.012 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.719048e-01 | 0.012 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.721020e-01 | 0.012 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.731105e-01 | 0.012 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.731105e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.734427e-01 | 0.012 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.741653e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.741653e-01 | 0.011 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.741653e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.741653e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.749969e-01 | 0.011 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.764247e-01 | 0.010 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.764247e-01 | 0.010 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.770049e-01 | 0.010 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.782826e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.782826e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.784865e-01 | 0.009 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.784865e-01 | 0.009 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.795989e-01 | 0.009 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.801301e-01 | 0.009 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.808843e-01 | 0.008 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.817909e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.817909e-01 | 0.008 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.820854e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.820854e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.820854e-01 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.826863e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.832290e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.836525e-01 | 0.007 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.836525e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.844399e-01 | 0.007 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.844399e-01 | 0.007 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.847376e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.847376e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.850826e-01 | 0.007 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.850826e-01 | 0.007 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.856199e-01 | 0.006 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.863877e-01 | 0.006 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.863877e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.863877e-01 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.864840e-01 | 0.006 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.871255e-01 | 0.006 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.878901e-01 | 0.005 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.886607e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.886654e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.893409e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.894650e-01 | 0.005 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.896572e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.896572e-01 | 0.005 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.905623e-01 | 0.004 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.910710e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.913882e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.917570e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.917570e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.923915e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.928296e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.928296e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.928296e-01 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.931150e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.934572e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.934572e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.936027e-01 | 0.003 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.940214e-01 | 0.003 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.940300e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.944845e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.945526e-01 | 0.002 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.948732e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.950255e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.952395e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.954646e-01 | 0.002 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.955329e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.955542e-01 | 0.002 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.958617e-01 | 0.002 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.960484e-01 | 0.002 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.962337e-01 | 0.002 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.962337e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.964665e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.966086e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.971317e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.973447e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.973498e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.973498e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.974971e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.975043e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.976121e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.976999e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.977503e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.980121e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.980667e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.981863e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.982141e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.984047e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.984047e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.984901e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.985924e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.986771e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.986796e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.989538e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.989538e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990288e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.990454e-01 | 0.000 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.990454e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.991009e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.991624e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.992054e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.992054e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.992292e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992751e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.992751e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.993386e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.993613e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.993966e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.993995e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994495e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.994918e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.995027e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.997002e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997006e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997104e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.997269e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.997614e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.997642e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997801e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998090e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998331e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998438e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998477e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998844e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.998882e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999037e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999119e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999334e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999377e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999446e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999459e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999531e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999558e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999643e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999689e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999758e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999766e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999913e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999928e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999954e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999961e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999961e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999965e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999965e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999971e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999981e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999982e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999986e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999990e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999992e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999993e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999994e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999996e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 6.661338e-15 | 14.176 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.215650e-15 | 14.085 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.419487e-14 | 13.466 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.273559e-14 | 13.278 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.218048e-14 | 13.282 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.371947e-12 | 11.359 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.455792e-12 | 11.073 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.520185e-12 | 11.070 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.924028e-11 | 10.534 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.551459e-11 | 10.450 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.521563e-10 | 9.598 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.810051e-10 | 9.167 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.166448e-10 | 9.088 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.715501e-09 | 8.766 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.925628e-09 | 8.715 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.925628e-09 | 8.715 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.170783e-09 | 8.286 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.924704e-09 | 8.160 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.735832e-09 | 8.111 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.062431e-08 | 7.974 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.724226e-08 | 7.763 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.757607e-08 | 7.755 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.285091e-08 | 7.641 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.437333e-08 | 7.613 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.545679e-08 | 7.594 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.564240e-08 | 7.591 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.363522e-08 | 7.473 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.363522e-08 | 7.473 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.106260e-08 | 7.508 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.732540e-08 | 7.325 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.718157e-08 | 7.243 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.873660e-08 | 7.052 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.060082e-07 | 6.975 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.423512e-07 | 6.847 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.609561e-07 | 6.793 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.821638e-07 | 6.740 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.324996e-07 | 6.634 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.531786e-07 | 6.597 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.156499e-07 | 6.501 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.128694e-07 | 6.290 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.080267e-07 | 6.150 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.044081e-07 | 6.095 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.029344e-07 | 6.095 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.317186e-07 | 6.080 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.439151e-07 | 6.025 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.042891e-06 | 5.982 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.431766e-06 | 5.844 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.513612e-06 | 5.820 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.036973e-06 | 5.691 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.268766e-06 | 5.644 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.424845e-06 | 5.615 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.569688e-06 | 5.590 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.393102e-06 | 5.469 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.354940e-06 | 5.474 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.673058e-06 | 5.435 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.001323e-06 | 5.398 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.020059e-06 | 5.396 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.451240e-06 | 5.352 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.897470e-06 | 5.310 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.952230e-06 | 5.305 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.682608e-06 | 5.245 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.965291e-06 | 5.224 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.931468e-06 | 5.227 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.999232e-06 | 5.222 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.127043e-06 | 5.213 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.061295e-06 | 5.151 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.046126e-05 | 4.980 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.006288e-05 | 4.997 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.406936e-05 | 4.852 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.817113e-05 | 4.741 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.760526e-05 | 4.754 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.166530e-05 | 4.664 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.178219e-05 | 4.662 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.206819e-05 | 4.494 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.188593e-05 | 4.496 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.371145e-05 | 4.472 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.425046e-05 | 4.465 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.031117e-05 | 4.395 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.044405e-05 | 4.393 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.435510e-05 | 4.353 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.308557e-05 | 4.366 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.837941e-05 | 4.315 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.486691e-05 | 4.261 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.109997e-05 | 4.148 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.298466e-05 | 4.137 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.364615e-05 | 4.133 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.442453e-05 | 4.128 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.752858e-05 | 4.111 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.245575e-05 | 4.084 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.245575e-05 | 4.084 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.036231e-05 | 4.044 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.865359e-05 | 4.006 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.019466e-04 | 3.992 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.364854e-04 | 3.865 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.459755e-04 | 3.836 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.581217e-04 | 3.801 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.731172e-04 | 3.762 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.685000e-04 | 3.773 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.866146e-04 | 3.729 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.866146e-04 | 3.729 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.904796e-04 | 3.720 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.906769e-04 | 3.720 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.152043e-04 | 3.667 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.156820e-04 | 3.666 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.584276e-04 | 3.588 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.584276e-04 | 3.588 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.636573e-04 | 3.579 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.192758e-04 | 3.496 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.321984e-04 | 3.479 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.441427e-04 | 3.463 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.761579e-04 | 3.425 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.764483e-04 | 3.424 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.409877e-04 | 3.356 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.480257e-04 | 3.349 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.732529e-04 | 3.325 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.893820e-04 | 3.310 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.176244e-04 | 3.286 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.998356e-04 | 3.222 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.243972e-04 | 3.205 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.598607e-04 | 3.181 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.608706e-04 | 3.180 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.086264e-04 | 3.150 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.086264e-04 | 3.150 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.023300e-04 | 3.153 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.976716e-04 | 3.156 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.088399e-04 | 3.149 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.255379e-04 | 3.139 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.888110e-04 | 3.103 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.980214e-04 | 3.098 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.025931e-04 | 3.096 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.025931e-04 | 3.096 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.786729e-04 | 3.056 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.874996e-04 | 3.052 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.876098e-04 | 3.005 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.685678e-04 | 3.014 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.016658e-03 | 2.993 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.505720e-04 | 3.022 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.379211e-04 | 3.028 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.910678e-04 | 3.004 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.017594e-03 | 2.992 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.029039e-03 | 2.988 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.038424e-03 | 2.984 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.044090e-03 | 2.981 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.132449e-03 | 2.946 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.132449e-03 | 2.946 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.273537e-03 | 2.895 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.179626e-03 | 2.928 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.230915e-03 | 2.910 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.184061e-03 | 2.927 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.216686e-03 | 2.915 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.159322e-03 | 2.936 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.273537e-03 | 2.895 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.242740e-03 | 2.906 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.314376e-03 | 2.881 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.314376e-03 | 2.881 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.336050e-03 | 2.874 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.380855e-03 | 2.860 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.473738e-03 | 2.832 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.555080e-03 | 2.808 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.555080e-03 | 2.808 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.599414e-03 | 2.796 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.701079e-03 | 2.769 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.853226e-03 | 2.732 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.858702e-03 | 2.731 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.967455e-03 | 2.706 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.968571e-03 | 2.706 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.797780e-03 | 2.745 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.968571e-03 | 2.706 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.933074e-03 | 2.714 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.155120e-03 | 2.667 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.155120e-03 | 2.667 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.220553e-03 | 2.654 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.290161e-03 | 2.640 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.290161e-03 | 2.640 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.332988e-03 | 2.632 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.332988e-03 | 2.632 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.459608e-03 | 2.609 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.535138e-03 | 2.596 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.671416e-03 | 2.573 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.682561e-03 | 2.571 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.719431e-03 | 2.566 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.799013e-03 | 2.553 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.836753e-03 | 2.547 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.286853e-03 | 2.483 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.286853e-03 | 2.483 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.111989e-03 | 2.507 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.202572e-03 | 2.495 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.301387e-03 | 2.481 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.301387e-03 | 2.481 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.444622e-03 | 2.463 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.474024e-03 | 2.459 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.550406e-03 | 2.450 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.836853e-03 | 2.416 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.836853e-03 | 2.416 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.943296e-03 | 2.404 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.990423e-03 | 2.399 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.990423e-03 | 2.399 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.127845e-03 | 2.384 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.127845e-03 | 2.384 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.138942e-03 | 2.383 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.138942e-03 | 2.383 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.153189e-03 | 2.382 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.243552e-03 | 2.372 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.243552e-03 | 2.372 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.243552e-03 | 2.372 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.443113e-03 | 2.352 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.320186e-03 | 2.364 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.872039e-03 | 2.312 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.872039e-03 | 2.312 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.872039e-03 | 2.312 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.643321e-03 | 2.333 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.578900e-03 | 2.339 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.914644e-03 | 2.309 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.977985e-03 | 2.303 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.166146e-03 | 2.287 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.196747e-03 | 2.284 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.246512e-03 | 2.280 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.508055e-03 | 2.259 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.508055e-03 | 2.259 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.508055e-03 | 2.259 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.508055e-03 | 2.259 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.479858e-03 | 2.188 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.479858e-03 | 2.188 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.479858e-03 | 2.188 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.479858e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.479858e-03 | 2.188 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.719545e-03 | 2.243 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.653176e-03 | 2.248 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.248091e-03 | 2.204 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.373648e-03 | 2.196 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.173108e-03 | 2.209 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.173108e-03 | 2.209 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.173108e-03 | 2.209 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.173108e-03 | 2.209 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.823306e-03 | 2.235 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.310449e-03 | 2.200 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.834105e-03 | 2.165 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.886799e-03 | 2.162 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.050882e-03 | 2.152 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.050882e-03 | 2.152 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.050882e-03 | 2.152 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.138531e-03 | 2.146 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.138531e-03 | 2.146 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.138531e-03 | 2.146 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.138531e-03 | 2.146 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.233007e-03 | 2.141 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.233007e-03 | 2.141 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.350906e-03 | 2.134 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.350906e-03 | 2.134 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.377255e-03 | 2.132 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.377255e-03 | 2.132 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.918791e-03 | 2.101 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.918791e-03 | 2.101 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.918791e-03 | 2.101 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.940724e-03 | 2.100 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.970447e-03 | 2.099 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.975753e-03 | 2.098 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.975753e-03 | 2.098 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.451801e-03 | 2.024 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.774275e-03 | 2.010 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.439918e-03 | 2.025 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.777901e-03 | 2.057 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.342462e-03 | 2.030 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.744773e-03 | 2.011 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.217889e-03 | 2.085 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.774275e-03 | 2.010 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.239483e-03 | 2.084 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.239483e-03 | 2.084 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.239483e-03 | 2.084 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.451801e-03 | 2.024 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.419710e-03 | 2.026 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.664012e-03 | 2.062 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.239483e-03 | 2.084 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.738778e-03 | 2.059 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.258776e-03 | 2.033 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.217889e-03 | 2.085 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.217889e-03 | 2.085 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.035916e-02 | 1.985 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.035916e-02 | 1.985 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.056610e-02 | 1.976 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.064529e-02 | 1.973 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.069383e-02 | 1.971 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.100062e-02 | 1.959 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.124547e-02 | 1.949 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.124547e-02 | 1.949 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.181867e-02 | 1.927 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.182338e-02 | 1.927 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.189917e-02 | 1.924 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.189917e-02 | 1.924 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.191186e-02 | 1.924 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.201667e-02 | 1.920 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.525744e-02 | 1.817 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.525744e-02 | 1.817 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.525744e-02 | 1.817 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.525744e-02 | 1.817 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.525744e-02 | 1.817 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.490717e-02 | 1.827 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.490717e-02 | 1.827 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.395207e-02 | 1.855 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.329373e-02 | 1.876 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.393568e-02 | 1.856 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.229166e-02 | 1.910 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.384684e-02 | 1.859 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.384684e-02 | 1.859 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.340716e-02 | 1.873 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.428635e-02 | 1.845 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.348403e-02 | 1.870 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.265249e-02 | 1.898 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.422440e-02 | 1.847 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.406298e-02 | 1.852 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.316866e-02 | 1.880 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.395207e-02 | 1.855 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.440460e-02 | 1.841 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.282733e-02 | 1.892 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.433876e-02 | 1.843 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.340716e-02 | 1.873 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.490717e-02 | 1.827 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.222543e-02 | 1.913 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.222543e-02 | 1.913 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.249201e-02 | 1.903 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.406298e-02 | 1.852 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.222543e-02 | 1.913 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.428635e-02 | 1.845 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.479097e-02 | 1.830 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.406298e-02 | 1.852 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.265249e-02 | 1.898 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.395207e-02 | 1.855 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.393568e-02 | 1.856 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.329373e-02 | 1.876 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.296718e-02 | 1.887 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.552682e-02 | 1.809 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.562563e-02 | 1.806 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.601848e-02 | 1.795 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.607228e-02 | 1.794 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.645042e-02 | 1.784 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.758185e-02 | 1.755 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.788705e-02 | 1.747 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.788705e-02 | 1.747 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.788705e-02 | 1.747 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.788705e-02 | 1.747 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.788705e-02 | 1.747 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.811857e-02 | 1.742 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.812066e-02 | 1.742 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.816871e-02 | 1.741 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.843954e-02 | 1.734 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.843954e-02 | 1.734 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.843954e-02 | 1.734 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.896671e-02 | 1.722 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.989105e-02 | 1.701 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.031854e-02 | 1.692 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.031854e-02 | 1.692 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.031854e-02 | 1.692 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.031854e-02 | 1.692 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.031854e-02 | 1.692 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.074348e-02 | 1.683 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.103397e-02 | 1.677 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.105021e-02 | 1.677 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.142197e-02 | 1.669 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.193001e-02 | 1.659 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.199284e-02 | 1.658 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.208381e-02 | 1.656 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.297079e-02 | 1.639 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.305963e-02 | 1.637 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.348351e-02 | 1.629 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.391659e-02 | 1.621 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.391659e-02 | 1.621 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.391659e-02 | 1.621 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.405230e-02 | 1.619 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.425154e-02 | 1.615 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.448699e-02 | 1.611 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.448699e-02 | 1.611 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.448699e-02 | 1.611 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.834451e-02 | 1.548 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.834451e-02 | 1.548 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.679722e-02 | 1.572 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.384825e-02 | 1.470 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.384825e-02 | 1.470 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.624528e-02 | 1.581 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.624528e-02 | 1.581 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.201146e-02 | 1.495 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.718058e-02 | 1.566 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.008132e-02 | 1.522 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.008132e-02 | 1.522 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.301386e-02 | 1.481 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.301386e-02 | 1.481 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.624528e-02 | 1.581 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.160708e-02 | 1.500 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.891951e-02 | 1.539 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.679722e-02 | 1.572 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.384825e-02 | 1.470 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.891951e-02 | 1.539 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.117907e-02 | 1.506 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.624528e-02 | 1.581 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.230922e-02 | 1.491 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.891951e-02 | 1.539 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.384825e-02 | 1.470 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.604960e-02 | 1.584 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.891951e-02 | 1.539 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.160708e-02 | 1.500 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.679722e-02 | 1.572 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.319661e-02 | 1.479 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.372000e-02 | 1.472 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.384825e-02 | 1.470 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.035263e-02 | 1.518 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.384825e-02 | 1.470 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.891951e-02 | 1.539 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.992045e-02 | 1.524 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.384825e-02 | 1.470 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.319661e-02 | 1.479 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.396063e-02 | 1.469 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.416421e-02 | 1.466 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.437947e-02 | 1.464 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.437947e-02 | 1.464 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.437947e-02 | 1.464 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.508724e-02 | 1.455 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.543668e-02 | 1.451 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.571687e-02 | 1.447 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.571687e-02 | 1.447 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.624222e-02 | 1.441 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.648260e-02 | 1.438 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.648260e-02 | 1.438 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.652250e-02 | 1.437 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.653347e-02 | 1.437 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.677174e-02 | 1.434 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.677174e-02 | 1.434 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.677174e-02 | 1.434 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.680939e-02 | 1.434 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.816422e-02 | 1.418 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.922946e-02 | 1.406 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.951545e-02 | 1.403 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.009850e-02 | 1.397 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.009850e-02 | 1.397 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.035714e-02 | 1.394 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.035714e-02 | 1.394 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.035714e-02 | 1.394 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.064929e-02 | 1.391 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.064929e-02 | 1.391 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.197587e-02 | 1.377 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.244054e-02 | 1.372 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.247163e-02 | 1.372 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.247163e-02 | 1.372 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.308426e-02 | 1.366 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.308426e-02 | 1.366 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.355142e-02 | 1.361 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.495843e-02 | 1.347 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.528213e-02 | 1.344 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.570761e-02 | 1.340 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.570761e-02 | 1.340 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.613847e-02 | 1.336 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.669653e-02 | 1.331 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.707206e-02 | 1.327 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.763489e-02 | 1.322 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.763489e-02 | 1.322 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 4.822057e-02 | 1.317 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.897580e-02 | 1.310 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.114293e-02 | 1.291 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.245919e-02 | 1.280 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.247824e-02 | 1.280 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.270612e-02 | 1.278 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.291438e-02 | 1.276 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.375757e-02 | 1.270 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.408542e-02 | 1.267 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 5.408542e-02 | 1.267 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 5.408542e-02 | 1.267 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.433569e-02 | 1.265 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.609708e-02 | 1.251 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.609708e-02 | 1.251 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.609708e-02 | 1.251 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.627405e-02 | 1.250 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.627405e-02 | 1.250 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.656943e-02 | 1.247 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.675572e-02 | 1.246 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.675572e-02 | 1.246 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.675572e-02 | 1.246 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.675572e-02 | 1.246 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.675572e-02 | 1.246 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.675572e-02 | 1.246 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.729096e-02 | 1.242 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.731180e-02 | 1.242 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.961463e-02 | 1.099 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 7.961463e-02 | 1.099 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 7.961463e-02 | 1.099 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.766267e-02 | 1.170 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.431466e-02 | 1.074 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.431466e-02 | 1.074 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.588928e-02 | 1.120 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.380924e-02 | 1.195 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.380924e-02 | 1.195 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.625371e-02 | 1.064 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.625371e-02 | 1.064 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.035042e-02 | 1.219 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.885927e-02 | 1.162 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.509310e-02 | 1.124 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.483400e-02 | 1.188 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.062698e-02 | 1.217 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.923141e-02 | 1.160 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.235335e-02 | 1.205 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.100710e-02 | 1.091 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.035042e-02 | 1.219 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.983120e-02 | 1.098 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.741761e-02 | 1.171 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.154354e-02 | 1.211 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.588928e-02 | 1.120 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.625371e-02 | 1.064 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.235335e-02 | 1.205 | 0 | 0 |
| Translation | R-HSA-72766 | 6.780121e-02 | 1.169 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.514028e-02 | 1.124 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.385783e-02 | 1.195 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.431466e-02 | 1.074 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.596607e-02 | 1.119 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.582396e-02 | 1.182 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.642054e-02 | 1.117 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.860524e-02 | 1.105 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.569632e-02 | 1.182 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.526686e-02 | 1.069 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.596607e-02 | 1.119 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.455026e-02 | 1.128 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.970949e-02 | 1.098 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.887581e-02 | 1.230 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.978620e-02 | 1.223 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.658848e-02 | 1.177 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.983120e-02 | 1.098 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.076260e-02 | 1.150 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.741761e-02 | 1.171 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.766267e-02 | 1.170 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.358843e-02 | 1.197 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.035042e-02 | 1.219 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.385783e-02 | 1.195 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.385783e-02 | 1.195 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.983120e-02 | 1.098 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.987430e-02 | 1.156 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.380924e-02 | 1.195 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.380924e-02 | 1.195 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.480096e-02 | 1.188 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.385783e-02 | 1.195 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.385783e-02 | 1.195 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.882724e-02 | 1.162 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.782153e-02 | 1.169 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.632424e-02 | 1.064 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.871978e-02 | 1.052 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.871978e-02 | 1.052 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.871978e-02 | 1.052 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.872407e-02 | 1.052 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.872407e-02 | 1.052 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.897174e-02 | 1.051 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.897174e-02 | 1.051 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.897174e-02 | 1.051 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.048419e-02 | 1.043 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.048419e-02 | 1.043 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.048419e-02 | 1.043 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.164319e-02 | 1.038 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.164319e-02 | 1.038 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.574458e-02 | 1.019 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.736802e-02 | 1.012 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.765392e-02 | 1.010 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.765392e-02 | 1.010 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.765392e-02 | 1.010 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.765392e-02 | 1.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.869100e-02 | 1.006 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.869100e-02 | 1.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.970471e-02 | 1.001 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.991573e-02 | 1.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.991573e-02 | 1.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.998330e-02 | 1.000 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.005352e-01 | 0.998 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.005352e-01 | 0.998 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.005352e-01 | 0.998 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.025197e-01 | 0.989 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.025197e-01 | 0.989 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.025197e-01 | 0.989 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.025197e-01 | 0.989 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.025197e-01 | 0.989 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.025197e-01 | 0.989 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.029565e-01 | 0.987 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.030582e-01 | 0.987 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.030582e-01 | 0.987 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.030582e-01 | 0.987 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.030582e-01 | 0.987 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.055783e-01 | 0.976 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.080604e-01 | 0.966 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.080604e-01 | 0.966 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.080604e-01 | 0.966 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.080604e-01 | 0.966 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.080604e-01 | 0.966 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.080604e-01 | 0.966 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.080604e-01 | 0.966 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.095296e-01 | 0.960 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.097726e-01 | 0.960 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.097726e-01 | 0.960 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.097726e-01 | 0.960 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.097726e-01 | 0.960 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.098524e-01 | 0.959 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.105925e-01 | 0.956 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.106744e-01 | 0.956 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.111474e-01 | 0.954 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.112112e-01 | 0.954 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.112696e-01 | 0.954 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.116420e-01 | 0.952 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.116420e-01 | 0.952 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.159758e-01 | 0.936 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.159758e-01 | 0.936 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.159758e-01 | 0.936 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.179754e-01 | 0.928 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.180930e-01 | 0.928 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.180930e-01 | 0.928 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.180930e-01 | 0.928 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.180930e-01 | 0.928 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.197246e-01 | 0.922 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.221227e-01 | 0.913 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.221227e-01 | 0.913 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.223052e-01 | 0.913 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.223052e-01 | 0.913 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.225816e-01 | 0.912 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.225816e-01 | 0.912 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.225816e-01 | 0.912 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.231636e-01 | 0.910 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.238071e-01 | 0.907 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.238071e-01 | 0.907 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.238071e-01 | 0.907 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.238071e-01 | 0.907 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.247101e-01 | 0.904 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.275381e-01 | 0.894 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.300372e-01 | 0.886 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective GALM causes GALAC4 | R-HSA-9931929 | 1.695731e-01 | 0.771 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.695731e-01 | 0.771 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.695731e-01 | 0.771 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.695731e-01 | 0.771 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.432572e-01 | 0.614 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.432572e-01 | 0.614 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.387051e-01 | 0.858 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.387051e-01 | 0.858 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.709352e-01 | 0.767 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.709352e-01 | 0.767 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.709352e-01 | 0.767 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.042286e-01 | 0.690 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.042286e-01 | 0.690 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.429619e-01 | 0.845 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.429619e-01 | 0.845 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.429619e-01 | 0.845 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.429619e-01 | 0.845 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.429619e-01 | 0.845 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.648725e-01 | 0.783 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.648725e-01 | 0.783 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.381434e-01 | 0.623 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.381434e-01 | 0.623 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.876910e-01 | 0.727 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.876910e-01 | 0.727 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.876910e-01 | 0.727 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.876910e-01 | 0.727 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.876910e-01 | 0.727 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.112575e-01 | 0.675 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.682377e-01 | 0.774 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.682377e-01 | 0.774 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.360490e-01 | 0.866 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.360490e-01 | 0.866 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.360490e-01 | 0.866 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.863940e-01 | 0.730 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.051450e-01 | 0.688 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.600254e-01 | 0.585 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.600254e-01 | 0.585 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.407772e-01 | 0.851 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.957411e-01 | 0.708 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.957411e-01 | 0.708 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.957411e-01 | 0.708 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.719856e-01 | 0.765 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.519299e-01 | 0.818 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.519299e-01 | 0.818 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.347718e-01 | 0.870 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.441224e-01 | 0.612 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.119081e-01 | 0.674 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.119081e-01 | 0.674 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.855469e-01 | 0.732 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.995100e-01 | 0.700 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.138448e-01 | 0.670 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.454167e-01 | 0.610 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.763706e-01 | 0.754 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.763706e-01 | 0.754 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.531780e-01 | 0.815 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.885716e-01 | 0.725 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.851213e-01 | 0.733 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.160496e-01 | 0.665 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.752229e-01 | 0.756 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.604400e-01 | 0.584 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.138448e-01 | 0.670 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.640157e-01 | 0.785 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.640157e-01 | 0.785 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.640157e-01 | 0.785 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.682377e-01 | 0.774 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.634789e-01 | 0.787 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.454167e-01 | 0.610 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.588546e-01 | 0.799 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.284823e-01 | 0.641 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.449397e-01 | 0.611 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.387051e-01 | 0.858 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.138448e-01 | 0.670 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.473501e-01 | 0.607 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.347718e-01 | 0.870 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.587682e-01 | 0.587 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.112575e-01 | 0.675 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.855469e-01 | 0.732 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.482954e-01 | 0.605 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.855469e-01 | 0.732 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.284823e-01 | 0.641 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.657613e-01 | 0.781 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.407772e-01 | 0.851 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.876938e-01 | 0.727 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.519299e-01 | 0.818 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.519299e-01 | 0.818 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.709352e-01 | 0.767 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.709352e-01 | 0.767 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.648725e-01 | 0.783 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.400206e-01 | 0.620 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.084115e-01 | 0.681 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.550079e-01 | 0.810 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.863940e-01 | 0.730 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.634789e-01 | 0.787 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.827478e-01 | 0.738 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.199449e-01 | 0.658 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.482954e-01 | 0.605 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.199449e-01 | 0.658 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.705405e-01 | 0.768 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.705405e-01 | 0.768 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.199449e-01 | 0.658 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.695731e-01 | 0.771 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.432572e-01 | 0.614 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.432572e-01 | 0.614 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.709352e-01 | 0.767 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.429619e-01 | 0.845 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.648725e-01 | 0.783 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.648725e-01 | 0.783 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.381434e-01 | 0.623 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.507527e-01 | 0.822 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.519299e-01 | 0.818 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.358324e-01 | 0.867 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.340138e-01 | 0.873 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.305062e-01 | 0.884 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.032256e-01 | 0.692 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.709352e-01 | 0.767 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.042286e-01 | 0.690 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.381434e-01 | 0.623 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.381434e-01 | 0.623 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.015137e-01 | 0.696 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.800273e-01 | 0.745 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.349184e-01 | 0.629 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.629053e-01 | 0.788 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.119081e-01 | 0.674 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.284823e-01 | 0.641 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.585995e-01 | 0.800 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.042286e-01 | 0.690 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.244135e-01 | 0.649 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.587682e-01 | 0.587 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.587682e-01 | 0.587 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.132652e-01 | 0.671 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.672884e-01 | 0.777 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.347718e-01 | 0.870 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.305356e-01 | 0.884 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.305356e-01 | 0.884 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.112575e-01 | 0.675 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.354178e-01 | 0.628 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.519299e-01 | 0.818 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.429619e-01 | 0.845 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.855469e-01 | 0.732 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.110977e-01 | 0.676 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.340138e-01 | 0.873 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.855469e-01 | 0.732 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.311089e-01 | 0.636 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.254695e-01 | 0.647 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.724448e-01 | 0.763 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.709352e-01 | 0.767 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.381434e-01 | 0.623 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.648121e-01 | 0.783 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.051450e-01 | 0.688 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.159785e-01 | 0.666 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.665916e-01 | 0.778 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.354178e-01 | 0.628 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.340138e-01 | 0.873 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.587682e-01 | 0.587 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.602026e-01 | 0.795 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.357160e-01 | 0.628 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.138448e-01 | 0.670 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.507527e-01 | 0.822 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.709352e-01 | 0.767 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.340138e-01 | 0.873 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.441224e-01 | 0.612 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.682377e-01 | 0.774 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.244135e-01 | 0.649 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.249282e-01 | 0.648 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.441224e-01 | 0.612 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.254695e-01 | 0.647 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.383806e-01 | 0.859 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.467941e-01 | 0.833 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.995100e-01 | 0.700 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.482768e-01 | 0.605 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.531780e-01 | 0.815 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.482954e-01 | 0.605 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.354178e-01 | 0.628 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.507527e-01 | 0.822 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.051450e-01 | 0.688 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.610853e-01 | 0.583 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.626642e-01 | 0.581 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.626642e-01 | 0.581 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.626642e-01 | 0.581 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.626642e-01 | 0.581 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.626642e-01 | 0.581 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.641957e-01 | 0.578 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.641957e-01 | 0.578 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.641957e-01 | 0.578 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.641957e-01 | 0.578 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.677759e-01 | 0.572 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.723076e-01 | 0.565 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.723076e-01 | 0.565 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.723076e-01 | 0.565 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.742753e-01 | 0.562 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.742753e-01 | 0.562 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.767425e-01 | 0.558 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.785435e-01 | 0.555 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.801778e-01 | 0.553 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.801778e-01 | 0.553 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.817461e-01 | 0.550 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.845591e-01 | 0.546 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.849419e-01 | 0.545 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.849419e-01 | 0.545 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.849419e-01 | 0.545 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.849419e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.849419e-01 | 0.545 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 2.872230e-01 | 0.542 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.872230e-01 | 0.542 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.899945e-01 | 0.538 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.917768e-01 | 0.535 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.950194e-01 | 0.530 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.979111e-01 | 0.526 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.979111e-01 | 0.526 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.979111e-01 | 0.526 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.979111e-01 | 0.526 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.979111e-01 | 0.526 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.045861e-01 | 0.516 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.051404e-01 | 0.516 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.058934e-01 | 0.514 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.058934e-01 | 0.514 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.064102e-01 | 0.514 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.064102e-01 | 0.514 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.064102e-01 | 0.514 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.064102e-01 | 0.514 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.064102e-01 | 0.514 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.064102e-01 | 0.514 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.064102e-01 | 0.514 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.064102e-01 | 0.514 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.064102e-01 | 0.514 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.100387e-01 | 0.509 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.104072e-01 | 0.508 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.104072e-01 | 0.508 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.158183e-01 | 0.501 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.158183e-01 | 0.501 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.169867e-01 | 0.499 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.286535e-01 | 0.483 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.338546e-01 | 0.476 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.338546e-01 | 0.476 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.338546e-01 | 0.476 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.351967e-01 | 0.475 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.351967e-01 | 0.475 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.351967e-01 | 0.475 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.351967e-01 | 0.475 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.356284e-01 | 0.474 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.361840e-01 | 0.473 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.381019e-01 | 0.471 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.401934e-01 | 0.468 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.401934e-01 | 0.468 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.401934e-01 | 0.468 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.401934e-01 | 0.468 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.401934e-01 | 0.468 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.401934e-01 | 0.468 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.401934e-01 | 0.468 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.401934e-01 | 0.468 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.466822e-01 | 0.460 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.466822e-01 | 0.460 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.469258e-01 | 0.460 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.519766e-01 | 0.453 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.530457e-01 | 0.452 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.543487e-01 | 0.451 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.549428e-01 | 0.450 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.603069e-01 | 0.443 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.603069e-01 | 0.443 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.603069e-01 | 0.443 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.603069e-01 | 0.443 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.603069e-01 | 0.443 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.603069e-01 | 0.443 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.603069e-01 | 0.443 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.674229e-01 | 0.435 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.677320e-01 | 0.434 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.679770e-01 | 0.434 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.700250e-01 | 0.432 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.706497e-01 | 0.431 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.706497e-01 | 0.431 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.716022e-01 | 0.430 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 3.716022e-01 | 0.430 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 3.716022e-01 | 0.430 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.716022e-01 | 0.430 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.716022e-01 | 0.430 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.733849e-01 | 0.428 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.734454e-01 | 0.428 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.765695e-01 | 0.424 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.796662e-01 | 0.421 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.833675e-01 | 0.416 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.852704e-01 | 0.414 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.852704e-01 | 0.414 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.852704e-01 | 0.414 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.862017e-01 | 0.413 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.869753e-01 | 0.412 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.895694e-01 | 0.409 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.969044e-01 | 0.401 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.978382e-01 | 0.400 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.059947e-01 | 0.391 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.059947e-01 | 0.391 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.059947e-01 | 0.391 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.059947e-01 | 0.391 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.059947e-01 | 0.391 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.064461e-01 | 0.391 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.090008e-01 | 0.388 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.090008e-01 | 0.388 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.090008e-01 | 0.388 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.099980e-01 | 0.387 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.099980e-01 | 0.387 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.099980e-01 | 0.387 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.103282e-01 | 0.387 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.115718e-01 | 0.386 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.189935e-01 | 0.378 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.195870e-01 | 0.377 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.195870e-01 | 0.377 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.245089e-01 | 0.372 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.245089e-01 | 0.372 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.273700e-01 | 0.369 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.273700e-01 | 0.369 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.273700e-01 | 0.369 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.273700e-01 | 0.369 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.273700e-01 | 0.369 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.273700e-01 | 0.369 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.273700e-01 | 0.369 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.273700e-01 | 0.369 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.273700e-01 | 0.369 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.273700e-01 | 0.369 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.295498e-01 | 0.367 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.295498e-01 | 0.367 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.319833e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.319833e-01 | 0.365 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.328122e-01 | 0.364 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.344102e-01 | 0.362 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.377042e-01 | 0.359 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.377042e-01 | 0.359 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.377042e-01 | 0.359 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.377042e-01 | 0.359 | 0 | 0 |
| Metallothioneins bind metals | R-HSA-5661231 | 4.377042e-01 | 0.359 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.384889e-01 | 0.358 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.424655e-01 | 0.354 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.496023e-01 | 0.347 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.518241e-01 | 0.345 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.584368e-01 | 0.339 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.584368e-01 | 0.339 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.584368e-01 | 0.339 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.584368e-01 | 0.339 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.584368e-01 | 0.339 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.594331e-01 | 0.338 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.594331e-01 | 0.338 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.602836e-01 | 0.337 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.602836e-01 | 0.337 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.622106e-01 | 0.335 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.648422e-01 | 0.333 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.648422e-01 | 0.333 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.676718e-01 | 0.330 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.684668e-01 | 0.329 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.684668e-01 | 0.329 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.700202e-01 | 0.328 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.700202e-01 | 0.328 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.741427e-01 | 0.324 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.779326e-01 | 0.321 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.779326e-01 | 0.321 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.779326e-01 | 0.321 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.781917e-01 | 0.320 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 4.781917e-01 | 0.320 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.781917e-01 | 0.320 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.781917e-01 | 0.320 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.781917e-01 | 0.320 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.781917e-01 | 0.320 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.781917e-01 | 0.320 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.781917e-01 | 0.320 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.781917e-01 | 0.320 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.781917e-01 | 0.320 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.781917e-01 | 0.320 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.781917e-01 | 0.320 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.785278e-01 | 0.320 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.792224e-01 | 0.319 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.860098e-01 | 0.313 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.898583e-01 | 0.310 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.898583e-01 | 0.310 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.898583e-01 | 0.310 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.898583e-01 | 0.310 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.898583e-01 | 0.310 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.898583e-01 | 0.310 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.927970e-01 | 0.307 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.937587e-01 | 0.306 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.953846e-01 | 0.305 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.965291e-01 | 0.304 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.965291e-01 | 0.304 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.982007e-01 | 0.303 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.982007e-01 | 0.303 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.982007e-01 | 0.303 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.982007e-01 | 0.303 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.982007e-01 | 0.303 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.982007e-01 | 0.303 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.982007e-01 | 0.303 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.982007e-01 | 0.303 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.988066e-01 | 0.302 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.990788e-01 | 0.302 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.014436e-01 | 0.300 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.032305e-01 | 0.298 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.062700e-01 | 0.296 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.115624e-01 | 0.291 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.126133e-01 | 0.290 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.126133e-01 | 0.290 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.126133e-01 | 0.290 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.126133e-01 | 0.290 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.245056e-01 | 0.280 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.245056e-01 | 0.280 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.245056e-01 | 0.280 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.245056e-01 | 0.280 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.245056e-01 | 0.280 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.245056e-01 | 0.280 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.245056e-01 | 0.280 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.245056e-01 | 0.280 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.245056e-01 | 0.280 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.245056e-01 | 0.280 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.245056e-01 | 0.280 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.245056e-01 | 0.280 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.245056e-01 | 0.280 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.245056e-01 | 0.280 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.245056e-01 | 0.280 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.245056e-01 | 0.280 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.245056e-01 | 0.280 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.263440e-01 | 0.279 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.268464e-01 | 0.278 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.268464e-01 | 0.278 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.268464e-01 | 0.278 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.268464e-01 | 0.278 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.268464e-01 | 0.278 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.276312e-01 | 0.278 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.276312e-01 | 0.278 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.285611e-01 | 0.277 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.285611e-01 | 0.277 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.295949e-01 | 0.276 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.328597e-01 | 0.273 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.458687e-01 | 0.263 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.463076e-01 | 0.263 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.463076e-01 | 0.263 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.463076e-01 | 0.263 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.495832e-01 | 0.260 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.495832e-01 | 0.260 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.495832e-01 | 0.260 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.495832e-01 | 0.260 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.495832e-01 | 0.260 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.495832e-01 | 0.260 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.495832e-01 | 0.260 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.495832e-01 | 0.260 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.495832e-01 | 0.260 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.543627e-01 | 0.256 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.543627e-01 | 0.256 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.543627e-01 | 0.256 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.543627e-01 | 0.256 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.543627e-01 | 0.256 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.543627e-01 | 0.256 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.592864e-01 | 0.252 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.667114e-01 | 0.247 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.667114e-01 | 0.247 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.667114e-01 | 0.247 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.667114e-01 | 0.247 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.667114e-01 | 0.247 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.667114e-01 | 0.247 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.667114e-01 | 0.247 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.667114e-01 | 0.247 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.667114e-01 | 0.247 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 5.667114e-01 | 0.247 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.667114e-01 | 0.247 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.683543e-01 | 0.245 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.696891e-01 | 0.244 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.709212e-01 | 0.243 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.709212e-01 | 0.243 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.709212e-01 | 0.243 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.709212e-01 | 0.243 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.716781e-01 | 0.243 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.807245e-01 | 0.236 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.807245e-01 | 0.236 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.807245e-01 | 0.236 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.807245e-01 | 0.236 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.807245e-01 | 0.236 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.807245e-01 | 0.236 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.807245e-01 | 0.236 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.807245e-01 | 0.236 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.867480e-01 | 0.232 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.916207e-01 | 0.228 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.921965e-01 | 0.228 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.042777e-01 | 0.219 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.051732e-01 | 0.218 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.051732e-01 | 0.218 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.051732e-01 | 0.218 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.051732e-01 | 0.218 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.051732e-01 | 0.218 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.051732e-01 | 0.218 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.051732e-01 | 0.218 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.051732e-01 | 0.218 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.051732e-01 | 0.218 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.051732e-01 | 0.218 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.051732e-01 | 0.218 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.051732e-01 | 0.218 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.059199e-01 | 0.218 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.059199e-01 | 0.218 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.059199e-01 | 0.218 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.059199e-01 | 0.218 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.059199e-01 | 0.218 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.116626e-01 | 0.213 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.116626e-01 | 0.213 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.116626e-01 | 0.213 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.130016e-01 | 0.213 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.141455e-01 | 0.212 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.183906e-01 | 0.209 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.197826e-01 | 0.208 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.299484e-01 | 0.201 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.299484e-01 | 0.201 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.299484e-01 | 0.201 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.299484e-01 | 0.201 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.299484e-01 | 0.201 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.299484e-01 | 0.201 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.310330e-01 | 0.200 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.310330e-01 | 0.200 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.310330e-01 | 0.200 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.320739e-01 | 0.199 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.350146e-01 | 0.197 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.350146e-01 | 0.197 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.350146e-01 | 0.197 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.402229e-01 | 0.194 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.402229e-01 | 0.194 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.402229e-01 | 0.194 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.402229e-01 | 0.194 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.402229e-01 | 0.194 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.402229e-01 | 0.194 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.402229e-01 | 0.194 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.402229e-01 | 0.194 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.402229e-01 | 0.194 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.402229e-01 | 0.194 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.402229e-01 | 0.194 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.402229e-01 | 0.194 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.402229e-01 | 0.194 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.402229e-01 | 0.194 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.402229e-01 | 0.194 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.497229e-01 | 0.187 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.497229e-01 | 0.187 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.528184e-01 | 0.185 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.528184e-01 | 0.185 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.528184e-01 | 0.185 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.528184e-01 | 0.185 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.543620e-01 | 0.184 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.615924e-01 | 0.179 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.668257e-01 | 0.176 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.721631e-01 | 0.173 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.721631e-01 | 0.173 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.721631e-01 | 0.173 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.721631e-01 | 0.173 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.721631e-01 | 0.173 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.721631e-01 | 0.173 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.721631e-01 | 0.173 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.721631e-01 | 0.173 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.721631e-01 | 0.173 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.721631e-01 | 0.173 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.745462e-01 | 0.171 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.745462e-01 | 0.171 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.745462e-01 | 0.171 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.745462e-01 | 0.171 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.769068e-01 | 0.169 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.785122e-01 | 0.168 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.820005e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.820144e-01 | 0.166 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.820152e-01 | 0.166 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.951545e-01 | 0.158 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.951545e-01 | 0.158 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.951545e-01 | 0.158 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.951545e-01 | 0.158 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 6.957325e-01 | 0.158 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.977816e-01 | 0.156 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.977816e-01 | 0.156 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.977816e-01 | 0.156 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.008320e-01 | 0.154 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.012694e-01 | 0.154 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.012694e-01 | 0.154 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.012694e-01 | 0.154 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.012694e-01 | 0.154 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.012694e-01 | 0.154 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.012694e-01 | 0.154 | 0 | 0 |
| PAOs oxidise polyamines to amines | R-HSA-141334 | 7.012694e-01 | 0.154 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.012694e-01 | 0.154 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.012694e-01 | 0.154 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.016803e-01 | 0.154 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.081408e-01 | 0.150 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.146706e-01 | 0.146 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.146706e-01 | 0.146 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.176362e-01 | 0.144 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.176362e-01 | 0.144 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.176362e-01 | 0.144 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.176362e-01 | 0.144 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.190890e-01 | 0.143 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.245734e-01 | 0.140 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.245734e-01 | 0.140 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.277931e-01 | 0.138 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.277931e-01 | 0.138 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.277931e-01 | 0.138 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.277931e-01 | 0.138 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.277931e-01 | 0.138 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.277931e-01 | 0.138 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 7.277931e-01 | 0.138 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.277931e-01 | 0.138 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.277931e-01 | 0.138 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.277931e-01 | 0.138 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.277931e-01 | 0.138 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.277931e-01 | 0.138 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.277931e-01 | 0.138 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.277931e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.296608e-01 | 0.137 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.296608e-01 | 0.137 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.329214e-01 | 0.135 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.329214e-01 | 0.135 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.331261e-01 | 0.135 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.331261e-01 | 0.135 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.331261e-01 | 0.135 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.331261e-01 | 0.135 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.377834e-01 | 0.132 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.377859e-01 | 0.132 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.428053e-01 | 0.129 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.444363e-01 | 0.128 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.444363e-01 | 0.128 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.485212e-01 | 0.126 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.505085e-01 | 0.125 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.505553e-01 | 0.125 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.505553e-01 | 0.125 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.519633e-01 | 0.124 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.519633e-01 | 0.124 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.519633e-01 | 0.124 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.519633e-01 | 0.124 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.519633e-01 | 0.124 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.519633e-01 | 0.124 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.519633e-01 | 0.124 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.519633e-01 | 0.124 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.557659e-01 | 0.122 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.557659e-01 | 0.122 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.615231e-01 | 0.118 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.615231e-01 | 0.118 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.615231e-01 | 0.118 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.615231e-01 | 0.118 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.615231e-01 | 0.118 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.615231e-01 | 0.118 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.627540e-01 | 0.118 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.627540e-01 | 0.118 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.667150e-01 | 0.115 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.669950e-01 | 0.115 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.669950e-01 | 0.115 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.669950e-01 | 0.115 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.669950e-01 | 0.115 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.669950e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.719145e-01 | 0.112 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.731584e-01 | 0.112 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.739886e-01 | 0.111 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.739886e-01 | 0.111 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.739886e-01 | 0.111 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.739886e-01 | 0.111 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.739886e-01 | 0.111 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.739886e-01 | 0.111 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.739886e-01 | 0.111 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.739886e-01 | 0.111 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.739886e-01 | 0.111 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.739886e-01 | 0.111 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.739886e-01 | 0.111 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.739886e-01 | 0.111 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.739886e-01 | 0.111 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.739886e-01 | 0.111 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.741781e-01 | 0.111 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.772875e-01 | 0.109 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.809306e-01 | 0.107 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.824835e-01 | 0.107 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.824835e-01 | 0.107 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.824835e-01 | 0.107 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.824835e-01 | 0.107 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.865185e-01 | 0.104 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.875889e-01 | 0.104 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.925366e-01 | 0.101 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.940594e-01 | 0.100 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.940594e-01 | 0.100 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.940594e-01 | 0.100 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.940594e-01 | 0.100 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.940594e-01 | 0.100 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.940594e-01 | 0.100 | 0 | 0 |
| Interconversion of polyamines | R-HSA-351200 | 7.940594e-01 | 0.100 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.940594e-01 | 0.100 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.966832e-01 | 0.099 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.970599e-01 | 0.099 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.970599e-01 | 0.099 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.970599e-01 | 0.099 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.070853e-01 | 0.093 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.072425e-01 | 0.093 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.074152e-01 | 0.093 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.085421e-01 | 0.092 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.107641e-01 | 0.091 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.107641e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.107641e-01 | 0.091 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.112452e-01 | 0.091 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.119688e-01 | 0.090 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.123488e-01 | 0.090 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.123488e-01 | 0.090 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.123488e-01 | 0.090 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.123488e-01 | 0.090 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.123488e-01 | 0.090 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.123488e-01 | 0.090 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.132168e-01 | 0.090 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.222133e-01 | 0.085 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.222133e-01 | 0.085 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.236360e-01 | 0.084 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.236360e-01 | 0.084 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.236360e-01 | 0.084 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.290149e-01 | 0.081 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.290149e-01 | 0.081 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.290149e-01 | 0.081 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.290149e-01 | 0.081 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.290149e-01 | 0.081 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.290149e-01 | 0.081 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.290149e-01 | 0.081 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.290149e-01 | 0.081 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.290149e-01 | 0.081 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.326328e-01 | 0.080 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.326328e-01 | 0.080 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.357153e-01 | 0.078 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.430014e-01 | 0.074 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.442018e-01 | 0.074 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.442018e-01 | 0.074 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.442018e-01 | 0.074 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.442018e-01 | 0.074 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.442018e-01 | 0.074 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.442018e-01 | 0.074 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.442018e-01 | 0.074 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.442018e-01 | 0.074 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.470412e-01 | 0.072 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.470412e-01 | 0.072 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.470412e-01 | 0.072 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.470412e-01 | 0.072 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.470412e-01 | 0.072 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.476646e-01 | 0.072 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.525449e-01 | 0.069 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.525449e-01 | 0.069 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.568604e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.576523e-01 | 0.067 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.576523e-01 | 0.067 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.580406e-01 | 0.066 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.580406e-01 | 0.066 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.580406e-01 | 0.066 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.580406e-01 | 0.066 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.580406e-01 | 0.066 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.580406e-01 | 0.066 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.580406e-01 | 0.066 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.669094e-01 | 0.062 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.670729e-01 | 0.062 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.675860e-01 | 0.062 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.675860e-01 | 0.062 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.703944e-01 | 0.060 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.706509e-01 | 0.060 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.706509e-01 | 0.060 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.706509e-01 | 0.060 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.706509e-01 | 0.060 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.706509e-01 | 0.060 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.749776e-01 | 0.058 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.750603e-01 | 0.058 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.755532e-01 | 0.058 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.768790e-01 | 0.057 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.768790e-01 | 0.057 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.768790e-01 | 0.057 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.771700e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.771700e-01 | 0.057 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.784625e-01 | 0.056 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.821417e-01 | 0.054 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.821417e-01 | 0.054 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.821417e-01 | 0.054 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.821417e-01 | 0.054 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.823502e-01 | 0.054 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.847000e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.855667e-01 | 0.053 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.855667e-01 | 0.053 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.855667e-01 | 0.053 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.855667e-01 | 0.053 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.888896e-01 | 0.051 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.899176e-01 | 0.051 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.918153e-01 | 0.050 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.926123e-01 | 0.049 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.926123e-01 | 0.049 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.926123e-01 | 0.049 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.926123e-01 | 0.049 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.926123e-01 | 0.049 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.926123e-01 | 0.049 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.926123e-01 | 0.049 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.926123e-01 | 0.049 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.926123e-01 | 0.049 | 0 | 0 |
| Amine Oxidase reactions | R-HSA-140179 | 8.926123e-01 | 0.049 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.926123e-01 | 0.049 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.926123e-01 | 0.049 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.936832e-01 | 0.049 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.936832e-01 | 0.049 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.936832e-01 | 0.049 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.948158e-01 | 0.048 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.951088e-01 | 0.048 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.012615e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.012615e-01 | 0.045 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.012615e-01 | 0.045 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.012615e-01 | 0.045 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.021533e-01 | 0.045 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.021533e-01 | 0.045 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.021533e-01 | 0.045 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.021533e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.021533e-01 | 0.045 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.021533e-01 | 0.045 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.021533e-01 | 0.045 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.021533e-01 | 0.045 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.048747e-01 | 0.043 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.083331e-01 | 0.042 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.108471e-01 | 0.041 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.108471e-01 | 0.041 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.108471e-01 | 0.041 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.108471e-01 | 0.041 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.108471e-01 | 0.041 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.108471e-01 | 0.041 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.108471e-01 | 0.041 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.108471e-01 | 0.041 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.187690e-01 | 0.037 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.187690e-01 | 0.037 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.196606e-01 | 0.036 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.205892e-01 | 0.036 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.210754e-01 | 0.036 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.210754e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.210754e-01 | 0.036 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.212418e-01 | 0.036 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.218006e-01 | 0.035 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.259873e-01 | 0.033 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.259873e-01 | 0.033 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.259873e-01 | 0.033 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.259873e-01 | 0.033 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.259873e-01 | 0.033 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.315038e-01 | 0.031 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.325646e-01 | 0.030 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.325646e-01 | 0.030 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.325646e-01 | 0.030 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.325646e-01 | 0.030 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.344323e-01 | 0.029 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.385578e-01 | 0.028 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.385578e-01 | 0.028 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.385578e-01 | 0.028 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.385578e-01 | 0.028 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.386078e-01 | 0.028 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.417169e-01 | 0.026 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.417169e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.417169e-01 | 0.026 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.439947e-01 | 0.025 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.440186e-01 | 0.025 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.440186e-01 | 0.025 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.440186e-01 | 0.025 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.440186e-01 | 0.025 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.449854e-01 | 0.025 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.460111e-01 | 0.024 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.460111e-01 | 0.024 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.476646e-01 | 0.023 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.476646e-01 | 0.023 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.476646e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.489697e-01 | 0.023 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.489944e-01 | 0.023 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.489944e-01 | 0.023 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.489944e-01 | 0.023 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.489944e-01 | 0.023 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.489944e-01 | 0.023 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.496552e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.518211e-01 | 0.021 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.521859e-01 | 0.021 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.535282e-01 | 0.021 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.535282e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.535282e-01 | 0.021 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.537117e-01 | 0.021 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.537117e-01 | 0.021 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.537117e-01 | 0.021 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.548028e-01 | 0.020 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.573736e-01 | 0.019 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.576593e-01 | 0.019 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.576593e-01 | 0.019 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.585190e-01 | 0.018 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.602937e-01 | 0.018 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.603551e-01 | 0.018 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.606109e-01 | 0.017 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.614233e-01 | 0.017 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.614233e-01 | 0.017 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.614233e-01 | 0.017 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.624946e-01 | 0.017 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.640825e-01 | 0.016 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.648529e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.648529e-01 | 0.016 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.677101e-01 | 0.014 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.679778e-01 | 0.014 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.686331e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.710019e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.717440e-01 | 0.012 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.719429e-01 | 0.012 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.731977e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.734193e-01 | 0.012 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.746887e-01 | 0.011 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.757830e-01 | 0.011 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.757830e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.757830e-01 | 0.011 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.769310e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.773187e-01 | 0.010 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.779366e-01 | 0.010 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.779366e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.779366e-01 | 0.010 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.779366e-01 | 0.010 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.779366e-01 | 0.010 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.798174e-01 | 0.009 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.798989e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.833156e-01 | 0.007 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.833156e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.833156e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.833156e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.833603e-01 | 0.007 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.846413e-01 | 0.007 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.847997e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.858591e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.860739e-01 | 0.006 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.861519e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.861519e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.869218e-01 | 0.006 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.869837e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.873838e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.873838e-01 | 0.006 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.873838e-01 | 0.006 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.874630e-01 | 0.005 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.885063e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.889975e-01 | 0.005 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.895289e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.901711e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.904606e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.909427e-01 | 0.004 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.915223e-01 | 0.004 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.916741e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.920828e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.927874e-01 | 0.003 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.928745e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.940141e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.942001e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.946572e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.946572e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.947762e-01 | 0.002 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.950790e-01 | 0.002 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.954746e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.954746e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.957457e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.958267e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.958774e-01 | 0.002 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.960813e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.965789e-01 | 0.001 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.967438e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.969203e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.969203e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.970030e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.970030e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.970030e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.970697e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.974138e-01 | 0.001 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.976441e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.976441e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.977401e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.979003e-01 | 0.001 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.983779e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.983779e-01 | 0.001 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.985224e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.985862e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.986540e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.987357e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.987403e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.987739e-01 | 0.001 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.987739e-01 | 0.001 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.987739e-01 | 0.001 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.988832e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.988982e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.989069e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990733e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.990733e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.991113e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.991559e-01 | 0.000 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.992162e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.992406e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.992797e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.992997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.993418e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993621e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.993920e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.994707e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.994870e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.994870e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.994885e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.995672e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996374e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.996682e-01 | 0.000 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.996923e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997175e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.997564e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998106e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998270e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998450e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998466e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998782e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998813e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998853e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.998965e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999222e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999346e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999534e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999591e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999786e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999789e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999861e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999896e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999919e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999960e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999973e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999978e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999982e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999988e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999994e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999998e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999998e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |